👪

Inheritance

1

Autosomal dominant HP:0000006

Heterozygous pathogenic KCNQ4 variants usually segregate as autosomal dominant hearing loss, with a 50% transmission probability for each child. Most affected individuals have an affected parent; the overall de novo proportion is unknown. GeneReviews describes complete penetrance with variable onset and severity. Once a familial pathogenic variant is established, prenatal and preimplantation genetic testing are possible.

Autosomal dominant inheritance De novo rate: Unknown; most affected individuals have an affected parent

Show evidence (5 references)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"DFNA2 nonsyndromic hearing loss is inherited in an autosomal dominant manner."

The GeneReviews statement of the inheritance mode.

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"Each child of an individual with DFNA2 nonsyndromic hearing loss has a 50% chance of inheriting the KCNQ4 pathogenic variant."

GeneReviews states the transmission risk for a confirmed familial KCNQ4 pathogenic variant; severity can vary among relatives.

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"Most individuals with DFNA2 nonsyndromic hearing loss have a parent with hearing loss; the proportion of individuals with a de novo KCNQ4 pathogenic variant is unknown."

The source for `de_novo_rate`. The unknown is the source's own statement, not a curation gap.

+ 2 more references

◈

Mechanistic Hypotheses

2

Outer hair cell degeneration alone accounts for advanced DFNA2A hearing loss

late_phase_cellular_target EMERGING

Evidence balance 1 support 3 refute

Outer hair cell degeneration explains much of the hearing deficit in the founding mixed-background mice. Expression studies proposed inner hair cell or neuronal involvement, and later null and missense models demonstrate additional injury. These findings challenge an exclusively outer-hair-cell account, but expression patterns alone do not establish a primary lesion. Age, genotype and background differ across studies and have not been isolated as explanations for every discrepancy. The relative contributions in human advanced disease remain uncertain; the models do not establish a universal treatment deadline.

Show evidence (4 references)

PMID:16437162 SUPPORT INDIRECT Model Organism

"We conclude that the hearing loss in DFNA2 is predominantly caused by a slow degeneration of OHCs resulting from chronic depolarization."

Predominant OHC involvement supports an OHC-centered account; it does not prove strict exclusivity, and the full text reports occasional old-animal IHC injury.

PMID:11042367 REFUTE INDIRECT Model Organism

"Our data suggest that the primary defect leading to initial high frequency loss and subsequent progressive hearing loss for all frequencies may be due to spiral ganglion and/or IHC dysfunction, rather than an OHC aberration."

Expression-based proposal challenges an exclusive outer-hair-cell account but does not directly demonstrate the causal cellular lesion.

PMID:16207888 REFUTE INDIRECT Model Organism

"Our expression data suggest that the primary defect leading to high-frequency loss in DFNA2 patients may be attributable to high levels of the dysfunctional Kcnq4_v3 variant in the spiral ganglion and inner hair cells in the basal hook region."

Expression-based proposal challenges an exclusive outer-hair-cell account but does not directly demonstrate the causal cellular lesion.

+ 1 more reference

Variant-specific gating and phosphoinositide dependence modify KCNQ4 channel function

variant_specific_channel_gating EMERGING

Evidence balance 4 support

R216H shifts channel activation toward more positive potentials. In a separate heterologous study, WT-R331Q forced heteromers respond to PIP2 augmentation or openers, whereas WT-G319D forced heteromers are hyperactive and can be downregulated. G319D and R331Q were VUS in that study, so these findings describe experimental channel mechanisms rather than established human mechanistic subtypes. Linopirdine reduced the hyperactive forced WT-G319D current to the WT-WT level; intracellular poly-L-lysine also reduced current. These are in-vitro pharmacology results without demonstrated human benefit.

Show evidence (4 references)

PMID:41639121 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Our analysis revealed that R216H impaired the voltage dependence of channel opening and both VSD activation components"

Voltage-clamp fluorometry in heterologously expressed channels shows altered activation. This does not itself demonstrate a dominant-negative mechanism.

PMID:34316018 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Based on these results, we concluded that p.G319D did not exert a dominant-negative inhibitory effect on WT channels"

G319D forced heteromers differ from the canonical dominant-negative model. The study's clinical classification remained VUS.

PMID:34316018 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Therefore, we concluded that pathogenic heteromeric WT-p.R331Q channels can be rescued by an increased PIP2 concentration, treatment with KCNQ openers, or both."

Experimental rescue result; the authors' word pathogenic in the discussion does not supersede their VUS classification table.

+ 1 more reference

?

Discussions and Knowledge Gaps

1

What is the prevalence or incidence of DFNA2A, as distinct from its share of autosomal dominant nonsyndromic hearing loss?

KNOWLEDGE GAP OPEN dfna2a_prevalence_unquantified

Attached to

disease#Autosomal Dominant Nonsyndromic Hearing Loss 2A

The cited 9.5% figure is six of 63 autosomal dominant molecular diagnoses in a referred testing cohort, not a population denominator. Rare missense carrier frequency also cannot be substituted for disease prevalence because many variants have uncertain or benign consequences. A population-based estimate was not identified in the reviewed sources.

Show evidence (2 references)

PMID:42162447 SUPPORT INDIRECT BACKGROUND Human Clinical

"Pathogenic variants in KCNQ4 account for ~9.5% of autosomal dominant nonsyndromic cases."

The background fraction derives from a diagnostic cohort and does not measure population prevalence.

PMID:35760561 SUPPORT INDIRECT BACKGROUND Computational

"approximately one in 100 people harbors missense variants in KCNQ4 (missense variants with minor allele frequency > 0.1% were excluded), but most are of unknown consequence"

Why a carrier-frequency figure cannot be substituted for a prevalence here. One person in a hundred carries a rare KCNQ4 missense variant and the great majority of those variants have no established consequence, so the population burden of the disease cannot be read off the allele data.

⚙

Pathophysiology

9

KCNQ4 Dominant-Negative Subunit Incorporation

Several pathogenic pore-region variants suppress wild-type Kv7.4 current when coexpressed, consistent with dominant-negative interference in tetrameric channels. The strength of suppression and the effect of subunit stoichiometry vary by allele. A universal rule that any single mutant subunit completely disables every channel is not established for all KCNQ4 variants. Gating defects and dominant-negative behavior need not be mutually exclusive.

Genetic context functional_impact_category: DOMINANT_NEGATIVE

voltage-gated potassium channel activity GO:0005249 ↓ DECREASED

Downstream

Loss of the Outer Hair Cell I(K,n) Potassium Conductance Dominant-negative channel dysfunction reduces the outer hair cell conductance. Null-model evidence establishes channel dependence; the exact residual current depends on genotype.

Inner Hair Cell Degeneration Kcnq4 deficiency can be accompanied by later injury to this population. Null-model evidence is indirect for dominant-negative human alleles, and intervening processes remain unresolved.

Spiral Ganglion Neuron Degeneration Kcnq4 deficiency can be accompanied by later injury to this population. Null-model evidence is indirect for dominant-negative human alleles, and intervening processes remain unresolved.

Prestin Mislocalization KCNQ4 deletion is associated with altered prestin localization; extrapolation to dominant-negative human alleles and the intervening process remain uncertain.

Show evidence (3 references)

PMID:21951272 SUPPORT PRIMARY RESULT In Vitro

"Co-expression of wt and KCNQ4 pore mutants suppressed currents to barely detectable levels."

The defining experiment for negative dominance - the mutant subunit suppresses the wild-type product rather than merely failing itself. This one is from the paper's KEY RESULTS, against the BACKGROUND sentence it is also cited for elsewhere.

PMID:10025409 SUPPORT In Vitro

"It abolishes the potassium currents of wild-type KCNQ4 on which it exerts a strong dominant-negative effect."

The original demonstration of negative dominance, from the paper that identified KCNQ4 as the DFNA2 gene. The effect is on the wild-type product, which is what distinguishes it from haploinsufficiency.

PMID:10025409 SUPPORT Human Clinical

"A mutation in this gene in a DFNA2 pedigree changes a residue in the KCNQ4 pore region."

Establishes the pore region as the location of the founding pathogenic variant.

KCNQ4 Haploinsufficiency from Truncating Variants

Reduced dosage is a proposed mechanism for some human truncating variants, distinct from the strong dominant-negative effects of many pore variants. Truncation position does not by itself establish nonsense-mediated decay, failed assembly or simple haploinsufficiency. Some early truncating families have later, milder hearing loss, but an early severe stop-variant case is also reported. Heterozygous null mice have normal hearing in the founding study, limiting a simple cross-species dosage explanation. Functional heterozygous assays can help distinguish effects but do not resolve the mechanism of every human allele.

Genetic context functional_impact_category: LOSS_OF_FUNCTION

voltage-gated potassium channel activity GO:0005249 ↓ DECREASED

Downstream

Loss of the Outer Hair Cell I(K,n) Potassium Conductance Reduced supply of functional subunits could decrease I(K,n), but the human truncation-to-cochlear-current link has not been directly demonstrated in these sources.

Show evidence (3 references)

PMID:23776385 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical

"In deletion mutations, haploinsufficiency has been proposed as the pathogenic mechanism of action."

Review synthesis presents dosage reduction as a proposed mechanism, not a demonstrated property of all truncations.

PMID:23776385 REFUTE DIRECT REVIEW SYNTHESIS Human Clinical

"However, the stop codon identified by Hildebrand et al did not fit this phenotype, because the affected individual had a more severe form of hearing loss requiring cochlear implantation during childhood."

An exception to the proposed later and milder truncation phenotype.

PMID:23776385 REFUTE DIRECT REVIEW SYNTHESIS Model Organism

"Those heterozygous for the knockout mutation did not show any hearing abnormalities, suggesting that only 50% of currents are required for normal hearing."

Heterozygous knockout animals did not reproduce a simple dosage-related hearing phenotype.

Loss of the Outer Hair Cell I(K,n) Potassium Conductance

Kv7.4 mediates the predominant I(K,n) conductance of outer hair cells and contributes to basolateral potassium efflux and the resting potential. Complete disruption abolishes this current in knockout mice; heterozygous variants can leave residual current, so reduction and complete abolition are distinguished by genotype.

cochlear outer hair cell CL:0000601

potassium ion transmembrane transport GO:0071805 ↓ DECREASED

Animal models

Kcnq4 knockout and dominant-negative knockin mouse Mouse recapitulates Direct electrophysiological measurement of the conductance loss in mutant outer hair cells.

Kcnq4 p.G228D humanized knock-in mouse Mouse recapitulates Reduced potassium current measured in outer hair cells of this allele-specific model.

kcnq4 morpholino knockdown zebrafish Zebrafish partially recapitulates Knocking the channel down reduces hair cell number and disturbs otolith morphology, which is consistent with the conductance being required for hair cell viability. It is not a measurement of the conductance itself.

Downstream

Chronic Outer Hair Cell Depolarization Without the standing outward potassium current, the cell cannot maintain its resting potential and sits depolarised.

Show evidence (2 references)

PMID:21951272 SUPPORT BACKGROUND In Vitro

"KCNQ4 mediates the predominant K(+) conductance, I(K,n) , of auditory outer hair cells (OHCs), and loss of KCNQ4 function leads to degeneration of OHCs resulting in progressive hearing loss."

Establishes Kv7.4 as the carrier of the predominant outer hair cell conductance and links its loss to the downstream degeneration. BACKGROUND: the sentence sits in this paper's BACKGROUND AND PURPOSE section, restating what was already known before its own patch-clamp experiments.

PMID:10025409 SUPPORT In Vitro

"Whereas mutations in KCNQ1 cause deafness by affecting endolymph secretion, the mechanism leading to KCNQ4-related hearing loss is intrinsic to outer hair cells."

Locates the lesion inside the hair cell rather than in the fluid environment around it. Worth recording explicitly because the sibling channelopathy in the same gene family reaches deafness by the opposite route, and the distinction is what makes an outer-hair-cell-directed therapy the rational target here.

Chronic Outer Hair Cell Depolarization

Loss or reduction of I(K,n) depolarizes outer hair cells and can impair their amplification before overt degeneration. Mouse and ex-vivo measurements support this functional stage; its reversibility and treatment window in people have not been established.

cochlear outer hair cell CL:0000601

Animal models

Kcnq4 knockout and dominant-negative knockin mouse Mouse recapitulates The model establishes the conductance loss and the resulting depolarization by direct measurement in the cells concerned.

Kcnq4 p.G228D humanized knock-in mouse Mouse recapitulates Depolarized resting potential measured in outer hair cells of this allele-specific model.

Downstream

Progressive Outer Hair Cell Degeneration Chronic depolarization is proposed to stress outer hair cells and contribute to degeneration. Increased calcium entry is a suggested intermediate, not directly established by the cited experiment.

Progressive High-Frequency Sensorineural Hearing Loss Depolarization impairs cochlear amplification before overt cell loss in mice; this provides a functional contribution to hearing loss alongside degeneration.

Show evidence (1 reference)

PMID:16437162 SUPPORT Model Organism

"The ensuing depolarization of OHCs impaired sound amplification."

Records the functional cost of depolarization independently of any cell loss.

Progressive Outer Hair Cell Degeneration

Outer hair cell degeneration accompanies progressive hearing loss in multiple Kcnq4 models. Basal loss precedes apical loss in some null and missense models, but the p.G322S model initially loses apical and middle-turn cells. Expression gradients and phenotype are therefore not a universal spatial rule. Inner hair cell and neuronal survival depend on model and observation age.

cochlear outer hair cell CL:0000601

Animal models

Kcnq4 knockout and dominant-negative knockin mouse Mouse recapitulates Selective outer hair cell loss paralleling the hearing decline.

Kcnq4 p.W277S knockin mouse Mouse recapitulates Reproduces both the progressive hearing loss and the outer hair cell degeneration, with the human hotspot allele rather than a null.

Kcnq4 p.G228D humanized knock-in mouse Mouse recapitulates Basal-to-apical outer hair cell loss in this allele-specific model.

Downstream

Progressive High-Frequency Sensorineural Hearing Loss Loss of cochlear amplification contributes to progressive sensorineural hearing loss. The frequency pattern varies by model and allele.

Show evidence (3 references)

PMID:16437162 SUPPORT Model Organism

"Inner hair cells and their afferent synapses remained mostly intact."

Establishes the selectivity of the early degeneration for outer hair cells.

PMID:31102762 SUPPORT Model Organism

"Cell loss progressed from basal to apical turns with age."

The spatial progression that maps onto the high-frequency-first clinical audiogram.

PMID:42162447 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Quantitative analysis revealed that, in heterozygous mice, OHC numbers were reduced by 48.9 and 60.0% in the apical and middle turns, respectively, whereas the basal turn remained largely unaffected."

At four weeks in the G322S model, early loss follows a different spatial pattern from a universal basal-first model.

Inner Hair Cell Degeneration

Inner hair cell loss was observed after outer hair cell degeneration in C3H/HeJ Kcnq4-null mice and at high-frequency locations in the humanized p.G228D study. Early preservation in other models does not exclude later injury. Mouse age, background and allele complicate comparisons; this is not a demonstrated universal second stage in human DFNA2A.

cochlear inner hair cell CL:0000589

Animal models

Kcnq4 knockout on the C3H/HeJ background Mouse recapitulates Demonstrates that inner hair cell and neuronal death occurs, and that it is a separate and much later event than outer hair cell loss.

Downstream

Severe-to-profound hearing impairment in later life Loss of this auditory cell population is proposed to contribute to severe hearing loss; the cited model does not establish its separate quantitative contribution in humans.

Show evidence (1 reference)

PMID:31102762 SUPPORT Model Organism

"In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."

The primary observation, and the qualifier that it was seen on a particular genetic background.

Spiral Ganglion Neuron Degeneration

Spiral ganglion neuron loss occurs later in the C3H/HeJ knockout study and is also reported in the 2025 KCNQ4-deficiency study. These observations establish a neuronal component in particular models without proving that preceding outer hair cell loss caused it or that all human carriers follow the same sequence.

spiral ganglion neuron CL:0011113

Animal models

Kcnq4 knockout on the C3H/HeJ background Mouse recapitulates Neuronal counts demonstrate later spiral ganglion loss in the null model.

Downstream

Severe-to-profound hearing impairment in later life Loss of this auditory cell population is proposed to contribute to severe hearing loss; the cited model does not establish its separate quantitative contribution in humans.

Show evidence (2 references)

PMID:31102762 SUPPORT Model Organism

"In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."

The primary observation, and the qualifier that it was seen on a particular genetic background.

PMID:40752593 SUPPORT Model Organism

"Spiral ganglion neurons (SGNs) also degenerate over time."

An independent report of the neuronal arm of this node, which matters because the earlier observation was attributed to one inbred background. Recorded separately rather than merged: it does not settle the hypothesis group below, but it removes the reading that neuronal loss is a C3H/HeJ artefact alone.

Progressive High-Frequency Sensorineural Hearing Loss

Symmetric, high-frequency-predominant sensorineural hearing loss commonly progresses to involve all frequencies. The clinical course varies by allele and family. GeneReviews describes severe-to-profound impairment by age 70 in its summarized cohorts; this is a historical clinical summary rather than a prospective guarantee for every newly identified allele.

Animal models

Kcnq4 p.G228D humanized knock-in mouse Mouse recapitulates Reproduces the human audiometric trajectory, including the spread from mid-and-high frequency loss to all frequencies, and the dose effect between heterozygotes and homozygotes.

Downstream

Progressive high-frequency sensorineural hearing loss The organism-level hearing deficit is expressed as the clinical audiometric phenotype.

Show evidence (1 reference)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"DFNA2 nonsyndromic hearing loss is characterized by symmetric, predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive across all frequencies."

The GeneReviews definition of the clinical outcome this chain produces.

Prestin Mislocalization

KCNQ4-deficient mice show altered prestin localization alongside other changes in cochlear organization. Prestin is relevant to outer hair cell electromotility, but the cited abstract does not isolate the contribution of its mislocalization to hearing loss or establish a human biomarker.

Show evidence (1 reference)

PMID:40752593 SUPPORT DIRECT PRIMARY RESULT Model Organism

"In this study, we demonstrate KCNQ4 deletion disrupts the localization of key proteins like prestin and BK channels, alters OHC organization, and induces apoptosis in sensory and SC."

The prestin-localization finding is retained separately from cell-death claims; accompanying findings are not treated as proven intervening steps.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

3

Progressive high-frequency sensorineural hearing loss Auditory HP:0001757

Course: PROGRESSIVE

Show evidence (2 references)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"DFNA2 nonsyndromic hearing loss is characterized by symmetric, predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive across all frequencies."

The GeneReviews clinical characterisation.

PMID:11915881 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Persons with this KCNQ4 mutation showed congenital, progressive high-frequency impairment without substantial loss of speech recognition during the first decades of life."

A family-specific congenital presentation; not all W276S families have the same reported onset.

Severe-to-profound hearing impairment in later life Auditory HP:0000408

Severity: SEVERE

Show evidence (1 reference)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"By age 70 years, all persons with DFNA2 nonsyndromic hearing loss have severe-to-profound hearing impairment."

Historical GeneReviews summary of late severity; interpreted with the chapter's variable age and severity and genotype-specific exceptions.

Vestibular hyperreactivity Vestibular HP:0001751

Show evidence (2 references)

PMID:11915881 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"A hyperactive vestibuloocular reflex was found in 3 of 11 cases: 2 persons were especially susceptible to motion sickness."

Direct human vestibular findings in the W276S family; denominator is the tested subset.

PMID:9193215 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"A significant finding was that 25% to 35% (depending on the exclusion criteria) of the patients showed an increased vestibulo-ocular reflex (hyperreactivity) as measured by rotatory responses."

The earlier DFNA2-linked family supplies a second human observation; this predates identification of KCNQ4.

🧬

Genetic Associations

1

KCNQ4 (Causal)

Gene: KCNQ4 hgnc:6298

Show evidence (12 references)

PMID:42162447 SUPPORT BACKGROUND Human Clinical

"Pathogenic variants in KCNQ4 account for ~9.5% of autosomal dominant nonsyndromic cases."

Secondary background estimate from the 2012–2014 diagnostic cohort; not a population prevalence or universal fraction of dominant hearing loss.

PMID:40898620 SUPPORT BACKGROUND Human Clinical

"The dominant-negative KCNQ4 p.W276S (c.827G>C) mutation represents a mutational hotspot in DFNA2, yet no effective treatments exist."

Identifies the recurrent variant and states the therapeutic gap this disease currently sits in. BACKGROUND for the same reason as the item above - a mouse antisense study, and this sentence is its framing rather than its result. The human primary source for the hotspot claim is the next item, which carries the same claim as a PRIMARY_RESULT.

PMID:15699719 SUPPORT PRIMARY RESULT Human Clinical

"All clinically affected participants were carriers of the W276S hotspot mutation in exon 5 of the KCNQ4 gene on chromosome 1p34."

All clinically affected participants carried W276S in a study of fifteen family members; this does not mean all fifteen were affected.

+ 9 more references

💊

Medical Actions

7

Hearing aids

Action: hearing aid fitting Ontology label: Rehabilitation NCIT:C15315

Platform: Device

Hearing aids support mild-to-moderate hearing loss. GeneReviews reports that amplification commonly becomes necessary between ages ten and 40; individual fitting depends on hearing and communication needs.

Show evidence (2 references)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"Hearing aids for those with mild-to-moderate hearing loss; consideration of cochlear implants when hearing loss is severe to profound"

The GeneReviews management recommendation, with the threshold for escalating from amplification to implantation.

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"Most affected persons initially require hearing aids to assist with sound amplification between ages ten and 40 years."

The age window over which amplification typically becomes necessary.

Cochlear implantation

Action: cochlear device implantation and hearing amplification Ontology label: Surgical Procedure NCIT:C15329

Platform: Device

Consider cochlear implantation for severe-to-profound hearing loss after assessment. GeneReviews also describes hybrid electroacoustic implants when low-frequency hearing remains useful.

Show evidence (2 references)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"Hearing aids for those with mild-to-moderate hearing loss; consideration of cochlear implants when hearing loss is severe to profound"

The GeneReviews management recommendation, with the threshold for escalating from amplification to implantation.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Hybrid implants combine two proven technologies – acoustic amplification and implant technology – to provide electroacoustic hearing."

Full clinical chapter describes the hybrid option for appropriate residual hearing.

KCNQ Channel Openers

Action: Pharmacotherapy NCIT:C15986

Agent: retigabine CHEBI:68584 zinc pyrithione CHEBI:32076

Platform: Small molecule

Experimental retigabine and zinc pyrithione potentiate KCNQ4 current. Homomeric pore mutants and forced mutant-containing concatemers can remain unresponsive, while WT-plus-pore-mutant coexpression permits restoration of total current, probably through residual wild-type homomers. Failure to repair a mutant channel therefore does not prove that a pore-variant carrier cannot benefit. Clinical efficacy is not established by these cell experiments. R331Q response is a separate forced-heteromer finding in a variant classified as VUS by the source.

Mechanism Target:

Loss of the Outer Hair Cell I(K,n) Potassium Conductance — The openers act on the conductance itself, upstream of depolarization and degeneration, which is why they would have to be given before cells are lost.

Show evidence (5 references)

PMID:21951272 SUPPORT In Vitro

"The strongest potentiation was observed with a combination of zinc pyrithione plus retigabine."

Identifies the drug combination and its effect on the channel.

PMID:21951272 REFUTE In Vitro

"DFNA2 mutations located in the channel's pore region abolished channel function and these mutant channels were completely unresponsive to channel openers."

Nonresponse of mutant channels limits direct repair of those channels. It does not refute total-current rescue in WT-plus-mutant coexpression or establish a patient exclusion rule.

PMID:34316018 SUPPORT In Vitro

"Phosphatidylinositol 4,5-bisphosphate (PIP2), an obligatory phospholipid for maintaining KCNQ channel activity, confers differential pharmacological sensitivity of channels to KCNQ openers."

Supplies the reason the response is allele-dependent rather than leaving it as an observation - PIP2 dependence differs by domain, so which opener helps depends on where the variant sits. This is what makes the strategy genotype-directed rather than simply unreliable.

+ 2 more references

Allele-Preferential Antisense Oligonucleotide Knockdown

Action: Pharmacotherapy NCIT:C15986

Platform: Antisense oligonucleotide RNase H knockdown Chemistry: 2′-MOE

RNA target: KCNQ4 hgnc:6298 mutant KCNQ4 mRNA (p.W276S allele)

ASO-123 is a 2′-MOE-wing/DNA-gap RNase H gapmer with a phosphorothioate backbone and 5-methylcytosine. In W277S heterozygous mice, a 15-μg round-window injection at P1–P3 preferentially reduced mutant transcript and partially improved hearing, outer hair cell survival and physiology through seven weeks. Preference is dose dependent: 30 μg also reduced wild-type transcripts and reduced pup survival. Benefit was incomplete and declined with time; neonatal mouse delivery does not establish efficacy, dosing or a treatment window in people. Human W276S selectivity was tested separately in transfected cells.

Mechanism Target:

KCNQ4 Dominant-Negative Subunit Incorporation — Removing the mutant transcript prevents the poisoned subunit being made at all, which is the most upstream point in this chain that a therapy can act on.

Show evidence (5 references)

PMID:40898620 SUPPORT Model Organism

"In a Kcnq4 p.W277S knockin mouse model mimicking DFNA2, ASO-123 preferentially suppressed mutant transcripts, attenuated progressive hearing loss, and improved outer hair cell survival while enhancing their electrophysiologic function."

The in vivo efficacy result, covering transcript selectivity, hearing, cell survival and function.

PMID:40898620 SUPPORT In Vitro

"In a systemic in vitro screen, ASO-123 demonstrated a knockdown of mutant Kcnq4 while preserving wild-type transcripts."

Establishes allele preference, which is the property the whole strategy depends on.

PMID:40898620 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Unexpectedly, although pups subjected to the 15 μg ASO-123 and 30 μg NT-ASO injections exhibited comparable survival rates with non-injected pups, the 30 μg ASO-123 injections significantly reduced survival."

Primary dose-limiting animal safety finding.

+ 2 more references

Adenine Base Editing of the Pathogenic Allele

Action: Gene Therapy NCIT:C15238

Platform: Gene editing

Dual AAV-ie split-ABE8e was delivered through the posterior semicircular canal at P2–P3 to mice carrying Kcnq4 G322S, equivalent to human G321S. The often-quoted 21.4–28.9% DNA correction was measured in bulk organ of Corti from homozygotes at three weeks; heterozygous baseline-adjusted DNA values were 7.9–16.7%. These are not percentages of corrected outer hair cells. In heterozygotes, the lower dose sustained partial hearing benefit to 32 weeks, with maximal 49.09-dB threshold improvement at 32 kHz at 20 weeks. Higher dose gave faster early improvement but earlier later deterioration. Cochlear inflammation, increased RNA A-to-I editing and systemic editor exposure limit a blanket safety claim. Human G321S correction was demonstrated in cells; clinical efficacy remains unestablished.

Mechanism Target:

KCNQ4 Dominant-Negative Subunit Incorporation — Correction restores wild-type sequence in a fraction of alleles; residual mutant expression and unedited cells remain.

Show evidence (4 references)

PMID:42162447 SUPPORT Model Organism

"Treatment reduced auditory brainstem response thresholds by up to 49.09 dB SPL at optimal frequencies, mitigated degeneration of hair cells, spiral ganglion neurons, and auditory nerve fibers, and partially restored outer hair cell electrophysiology."

The efficacy result across function, histology and electrophysiology.

PMID:42162447 SUPPORT Model Organism

"A dose-dependent therapeutic window emerged: higher doses promoted rapid recovery, whereas optimized lower doses minimized long-term toxicity and sustained functional benefit for at least 32 weeks."

The safety finding, which is the part that constrains translation rather than supporting it.

PMID:42162447 SUPPORT DIRECT PRIMARY RESULT Model Organism

"At the transcriptomic level, RNA-seq analysis identified an increase in A-to-I RNA editing events in the cochlea following AAV_ABE8e_N + C_322 administration"

Off-target RNA editing remains relevant despite reassuring tested DNA endpoints.

+ 1 more reference

School support and hearing surveillance

Provide educational assistance where needed, obtain at least annual audiograms and encourage avoidance of loud noise. These recommendations accompany individualized amplification and implant assessment.

Show evidence (3 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"For school-age children or adolescents, special assistance for the hearing impaired may be warranted and, where available, should be offered."

Educational support from the full chapter.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Audiograms should be obtained on an annual basis to follow progression of hearing loss."

Disease-specific surveillance interval.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Avoiding exposure to loud noise may reduce the rate of progression of high-frequency SNHL."

Clinical precaution; not proof of a genotype-specific noise interaction.

Genetic counseling

Action: Genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Discuss variable severity, 50% transmission risk, testing of relatives and reproductive testing once the familial pathogenic variant is established.

Show evidence (2 references)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"Each child of an individual with DFNA2 nonsyndromic hearing loss has a 50% chance of inheriting the KCNQ4 pathogenic variant."

GeneReviews states the transmission risk for a confirmed familial KCNQ4 pathogenic variant; severity can vary among relatives.

PMID:20301388 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Once the KCNQ4 pathogenic variant has been identified in a family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic testing for DFNA2 nonsyndromic hearing loss are possible."

Reproductive testing depends on a confirmed familial pathogenic variant.

🌍

Environmental Factors

2

Loud noise exposure

Noise is an aggravating exposure rather than a cause. GeneReviews lists avoiding loud noise under agents and circumstances to avoid, on the reasoning that it may slow the rate of high-frequency progression. The mechanistic rationale is that noise damages the same outer hair cells the channel defect is already killing, so the two insults share a target.

Show evidence (1 reference)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"Agents/circumstances to avoid: Avoiding exposure to loud noise may reduce the rate of progression of high-frequency SNHL."

The full GeneReviews avoidance statement including its section heading.

Mechanism Target:

EXACERBATES Progressive Outer Hair Cell Degeneration — Noise exposure is expected to add to the outer hair cell loss the channel defect produces. The link is indirect: the source states the clinical recommendation and the expected effect on progression rate, not a measured interaction in DFNA2A cochleae.

Show evidence (2 references)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"Avoiding exposure to loud noise may reduce the rate of progression of high-frequency SNHL."

The GeneReviews avoidance recommendation. Note the hedge in the source - "may reduce" - which is why the interaction is recorded as expected rather than demonstrated.

PMID:40752593 REFUTE Model Organism

"Despite these structural changes, noise exposure does not exacerbate OHC damage in our KCNQ4-deficient model."

The only experiment here that tests the interaction rather than assuming it, and it comes out against. A KCNQ4-deficient mouse exposed to noise showed no added outer hair cell damage. This does not overturn the clinical recommendation, which rests on general noise ototoxicity in an already-compromised cochlea, but it is the reason the edge stays INDIRECT_UNKNOWN_INTERMEDIATES rather than being upgraded on the strength of a plausible shared target.

Aminoglycoside antibiotic exposure

Aminoglycosides inhibit I(K,n) in isolated wild-type rat outer hair cells through reduced PIP2 availability. This provides a mechanistic convergence with KCNQ4 loss of function, but the cited study did not test increased drug susceptibility in DFNA2A carriers or a mutant model. A genotype-specific second hit remains an inference.

Show evidence (2 references)

PMID:20935082 SUPPORT BACKGROUND In Vitro

"OHC survival critically depends on a specific K+ conductance (I(K,n)) mediated by KCNQ4 (Kv7.4) channels."

States the dependence that makes the exposure and the genotype converge - outer hair cell survival rests on the same conductance both of them reduce.

PMID:20935082 SUPPORT BACKGROUND In Vitro

"As a common hallmark of all KCNQ isoforms, channel activity requires phosphatidylinositol(4,5)bisphosphate [PI(4,5)P₂]."

The complete cached chemical formula and sentence establish the PIP2 requirement.

Mechanism Target:

EXACERBATES Loss of the Outer Hair Cell I(K,n) Potassium Conductance — The intermediate is known and named - PIP2 depletion - which is why this is INDIRECT_KNOWN_INTERMEDIATES rather than unknown. The exposure acts on the same node the genetic lesion acts on, one step removed.

Show evidence (1 reference)

PMID:20935082 SUPPORT INDIRECT In Vitro

"The inhibition results from PI(4,5)P₂ depletion indicated by fluorescence imaging of cellular PI(4,5)P₂ and the dependence of inhibition on PI(4,5)P₂ availability and on PI(4,5)P₂ affinity of recombinant KCNQ channels."

The measured inhibition is attributed to PIP2 depletion in wild-type-cell experiments. This is indirect evidence for an interaction with DFNA2A genotype.

🔬

Diagnosis

3

Audiometry with a characteristic audioprofile

Diagnosis rests on the shape of the audiogram together with a dominant family history, confirmed by finding a heterozygous KCNQ4 pathogenic variant. Annual audiometry is the recommended surveillance, since the clinically relevant variable is rate of progression rather than a single threshold.

audiometric test NCIT:C38036

Show evidence (2 references)

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"The diagnosis of DFNA2 nonsyndromic hearing loss is established in an individual with a characteristic audioprofile, a family history consistent with autosomal dominant inheritance, and identification of a heterozygous pathogenic variant in KCNQ4."

The GeneReviews diagnostic criteria, naming all three components.

PMID:20301388 SUPPORT REVIEW SYNTHESIS Human Clinical

"At least annual audiogram to follow progression of hearing loss."

The recommended surveillance interval.

Multigene or genomic testing

A characteristic audioprofile raises suspicion, but other inherited hearing disorders overlap. Use a hearing-loss panel including KCNQ4 or comprehensive genomic testing, with appropriate sequence and copy-number assessment. Interpret variants with clinical, segregation and functional evidence; a VUS alone is not confirmatory.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"is most likely to identify the genetic cause of the condition while limiting identification of variants of uncertain significance and pathogenic variants in genes that do not explain the underlying phenotype."

Full chapter recommends a broader testing strategy rather than reliance on audiogram or single-gene testing alone.

Evaluation of at-risk relatives

Testing for the established familial pathogenic variant in infancy or early childhood can identify relatives who need hearing assessment and support before substantial recognized impairment.

Show evidence (1 reference)

PMID:20301388 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Determining in infancy or early childhood whether a family member of the proband has inherited a pathogenic variant in KCNQ4 allows for early support and management of the child and family."

Early family testing recommendation.

🐁

Animal Models

6

Kcnq4 knockout and dominant-negative knockin mouse

The founding study compared null animals with a G286S dominant-negative allele, equivalent to human G285S. Homozygous null and homozygous dominant-negative animals declined over weeks; heterozygous dominant-negative animals declined more slowly over months. Heterozygous null animals showed no hearing impairment.

Species

Mouse

Genotype

Kcnq4-/- and Kcnq4 dominant-negative DFNA2 allele knockin

Publication

PMID:16437162

Pathograph links

Chronic Outer Hair Cell Depolarization recapitulates fidelity: high observes: cellular The model establishes the conductance loss and the resulting depolarization by direct measurement in the cells concerned.

Limitations: Mouse cochlear ageing is compressed relative to the human decades-long course, so the model reports the mechanism faithfully but not its clinical tempo.

Show evidence (1 reference)

PMID:16437162 SUPPORT Model Organism

"It then declined over several weeks in Kcnq4-/- mice and over several months in mice carrying the dominant negative allele."

Shows the model reproduces progressive rather than congenital loss, and that the dominant allele is the slower of the two.

Loss of the Outer Hair Cell I(K,n) Potassium Conductance recapitulates fidelity: high observes: cellular Direct electrophysiological measurement of the conductance loss in mutant outer hair cells.

Readouts

Outer hair cell I(K,n) current

Direction: ABOLISHED

Interpretation: The specific conductance carried by Kv7.4 is absent in mutant outer hair cells.

Show evidence (1 reference)

PMID:16437162 SUPPORT In Vitro

"KCNQ4 disruption abolished the I(K,n) current of OHCs."

The electrophysiological measurement grounding the mechanism.

Show evidence (1 reference)

PMID:16437162 SUPPORT In Vitro

"KCNQ4 disruption abolished the I(K,n) current of OHCs."

The electrophysiological measurement of the conductance loss.

Progressive Outer Hair Cell Degeneration recapitulates fidelity: high observes: tissue Selective outer hair cell loss paralleling the hearing decline.

Show evidence (1 reference)

PMID:16437162 SUPPORT Model Organism

"This progressive hearing loss was paralleled by a selective degeneration of outer hair cells (OHCs)."

Histological confirmation of the degeneration this node asserts.

Kcnq4 knockout on the C3H/HeJ background

The same null allele on a different inbred background, made specifically to look for a mechanism behind the profound late phase that outer hair cell loss alone did not explain.

Species

Mouse

Genotype

Kcnq4 knockout backcrossed to C3H/HeJ

Publication

PMID:31102762

Pathograph links

Inner Hair Cell Degeneration recapitulates fidelity: moderate observes: tissue Demonstrates that inner hair cell and neuronal death occurs, and that it is a separate and much later event than outer hair cell loss.

Limitations: This null model differs from dominant human alleles. Background and age complicate comparison with the founding mixed-background study; the cited abstract does not isolate background as the cause of discrepant outcomes.

Divergences from the human mechanism

population mismatch qualifying

This null model differs from dominant human alleles. Background and age complicate comparison with the founding mixed-background study; the cited abstract does not isolate background as the cause of discrepant outcomes.

Show evidence (1 reference)

PMID:31102762 SUPPORT Model Organism

"In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."

The observation the model was built to test for.

Spiral Ganglion Neuron Degeneration recapitulates fidelity: moderate observes: tissue Neuronal counts demonstrate later spiral ganglion loss in the null model.

Readouts

Spiral ganglion neuron count

Direction: DECREASED

Interpretation: Neuronal loss measured directly rather than inferred from threshold shifts.

Show evidence (1 reference)

PMID:31102762 SUPPORT Model Organism

"In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."

The primary observation, and the qualifier that it was seen on a particular genetic background.

Show evidence (1 reference)

PMID:31102762 SUPPORT Model Organism

"In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."

The primary observation, and the qualifier that it was seen on a particular genetic background.

Kcnq4 p.W277S knockin mouse

An allele-specific knockin carrying the mouse equivalent of the recurrent human pore hotspot, built as the test bed for allele-preferential antisense knockdown.

Species

Mouse

Genotype

Kcnq4 p.W277S knockin (homologous to human KCNQ4 p.W276S)

Publication

PMID:40898620

Pathograph links

Progressive Outer Hair Cell Degeneration recapitulates fidelity: high observes: tissue Reproduces both the progressive hearing loss and the outer hair cell degeneration, with the human hotspot allele rather than a null.

Show evidence (1 reference)

PMID:40898620 SUPPORT BACKGROUND Model Organism

"We previously demonstrated that Kcnq4 p.W277S knockin mice harboring the homologous mutation to human KCNQ4 p.W276S recapitulate the progressive hearing loss observed in DFNA2 patients, including the predominant degeneration of OHCs."

States the model's fidelity to the human phenotype in the authors' own terms.

Kcnq4 p.G228D humanized knock-in mouse

A humanized knock-in carrying the mouse equivalent of a KCNQ4 variant found in a large Chinese family, made in both heterozygous and homozygous states. The human family carried both genotypes too, so the allele-dose comparison exists on both sides.

Species

Mouse

Genotype

Kcnq4 humanized homologous p.G228D knock-in, heterozygous and homozygous

Publication

PMID:35599357

Pathograph links

Progressive High-Frequency Sensorineural Hearing Loss recapitulates fidelity: high observes: organism Reproduces the human audiometric trajectory, including the spread from mid-and-high frequency loss to all frequencies, and the dose effect between heterozygotes and homozygotes.

Limitations: The mouse timescale is weeks where the human is decades, so the model reproduces the sequence and the dose relationship but not the tempo.

Show evidence (1 reference)

PMID:35599357 SUPPORT Model Organism

"The heterozygotes had mid-frequency and high-frequency hearing loss at 4 weeks, and moved toward all frequencies hearing loss at 12 weeks, while the homozygotes had severe-to-profound hearing loss at 8 weeks."

The progression and the allele-dose effect in one measurement. The homozygote result is the part the human family also shows, which is unusual for a dominant disease and is why the model is worth recording separately.

Loss of the Outer Hair Cell I(K,n) Potassium Conductance recapitulates fidelity: high observes: cellular Reduced potassium current measured in outer hair cells of this allele-specific model.

Readouts

Outer hair cell potassium current

Direction: DECREASED

Interpretation: Reduced current measured in isolated outer hair cells.

Show evidence (1 reference)

PMID:35599357 SUPPORT In Vitro

"The reduced K+ currents and depolarized resting potentials were revealed in OHCs."

Couples the reduced current to the depolarization this entry's chain asserts follows from it.

Show evidence (1 reference)

PMID:35599357 SUPPORT In Vitro

"The reduced K+ currents and depolarized resting potentials were revealed in OHCs."

Reduced K+ current in outer hair cells of the p.G228D model.

Chronic Outer Hair Cell Depolarization recapitulates fidelity: high observes: cellular Depolarized resting potential measured in outer hair cells of this allele-specific model.

Readouts

Outer hair cell resting membrane potential

Direction: INCREASED

Interpretation: Depolarization means a less negative resting voltage, not a decreased voltage.

Show evidence (1 reference)

PMID:35599357 SUPPORT In Vitro

"The reduced K+ currents and depolarized resting potentials were revealed in OHCs."

Couples the reduced current to the depolarization this entry's chain asserts follows from it.

Show evidence (1 reference)

PMID:35599357 SUPPORT In Vitro

"The reduced K+ currents and depolarized resting potentials were revealed in OHCs."

Depolarized resting potential in outer hair cells of the p.G228D model.

Progressive Outer Hair Cell Degeneration recapitulates fidelity: high observes: tissue Basal-to-apical outer hair cell loss in this allele-specific model.

Show evidence (1 reference)

PMID:35599357 SUPPORT Model Organism

"The degeneration of outer hair cells (OHCs) was observed from basal to apical turn of cochlea."

Independent confirmation of the spatial progression, in a third mouse model and on a different allele.

kcnq4 morpholino knockdown zebrafish

Acute developmental kcnq4 morpholino knockdown produced hair cell, otolith and motor abnormalities. Wild-type mRNA rescue supports a gene-related effect but does not exclude every off-target effect. This model does not reproduce a dominant-negative human allele or adult cochlear outer hair cell physiology. The same paper separately reports a human W275C family and cell/structural studies.

Species

Zebrafish

Genotype

kcnq4 morpholino knockdown, rescued with wild-type kcnq4 mRNA

Publication

PMID:41368761

Pathograph links

Loss of the Outer Hair Cell I(K,n) Potassium Conductance partially recapitulates fidelity: low observes: tissue Knocking the channel down reduces hair cell number and disturbs otolith morphology, which is consistent with the conductance being required for hair cell viability. It is not a measurement of the conductance itself.

Limitations: Zebrafish have no cochlea and no outer hair cells, so the target node's cell type does not exist in this organism; the readouts come from lateral line and inner ear hair cells instead. The knockdown is acute and developmental where the human disease is a progressive loss with variable age of onset, and morpholino knockdown reduces the whole gene product rather than reproducing a dominant-negative allele.

Divergences from the human mechanism

species mismatch qualifying

The cell type carrying I(K,n) in the human disease - the cochlear outer hair cell - has no zebrafish counterpart. The model reports on hair cells generally, so it supports the requirement for the channel in hair cell biology and not the specific conductance loss this node names.

boundary omission qualifying

Negative dominance is outside the model. A morpholino lowers the amount of wild-type product; it does not introduce a mutant subunit that poisons tetramers, which is the actual lesion in most patients.

Readouts

Inner ear hair cell number

Direction: DECREASED

Interpretation: Hair cell loss following knockdown, with otolith morphology and motor response as the accompanying structural and behavioural measures.

Show evidence (1 reference)

PMID:41368761 SUPPORT Model Organism

"This approach revealed significant changes in otolith morphology, a marked reduction in hair cell numbers, and abnormal motor responses."

The three measured outcomes of the knockdown.

Show evidence (1 reference)

PMID:41368761 SUPPORT Model Organism

"We used morpholino to knock down kcnq4 in zebrafish and rescued the phenotype by reintroducing wild-type kcnq4 mRNA."

Wild-type mRNA rescue supports specificity without proving absence of all reagent effects.

Kcnq4-null vestibular mouse

Sensitive reflex testing detected altered vestibulo-ocular responses without circling. Adult KCNQ4 and KCNQ5 localized to postsynaptic calyx-forming neurons, not vestibular hair cells; this revised the localization premise of the older study. Mouse altered reflexes do not establish the direction or frequency of human vestibular hyperreactivity.

Species

Mouse

Genotype

Kcnq4-/- with or without dominant-negative Kcnq5

Publication

PMID:23408425

Show evidence (2 references)

PMID:23408425 SUPPORT DIRECT PRIMARY RESULT Model Organism

"However, a milder form of vestibular dysfunction was apparent from altered vestibulo-ocular reflexes in Kcnq4(-/-)/Kcnq5(dn/dn) and Kcnq4(-/-) mice."

Measured model reflex alteration.

PMID:23408425 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we now show unambiguously that in adult mice both channels reside in postsynaptic calyx-forming neurons, but cannot be detected in the innervated hair cells"

Anatomical localization in adult mice, distinct from a human clinical phenotype.

{ }

Source YAML

click to show

name: Autosomal Dominant Nonsyndromic Hearing Loss 2A
creation_date: "2026-09-13T00:00:00Z"
category: Mendelian
synonyms:
- DFNA2A
- deafness, autosomal dominant 2A
- KCNQ4-related autosomal dominant nonsyndromic hearing loss
- autosomal dominant nonsyndromic deafness 2A
- DFNA2 nonsyndromic hearing loss
description: >-
  Autosomal dominant nonsyndromic hearing loss 2A (DFNA2A) is caused by pathogenic KCNQ4 variants affecting
  the Kv7.4 potassium channel. Dominant-negative loss of channel function is a major mechanism. Reduced
  outer hair cell I(K,n) conductance produces chronic depolarization, impaired cochlear amplification
  and progressive degeneration in experimental models. Variant effects depend on channel assembly and
  gating; functional assay results alone do not establish clinical pathogenicity. Hearing loss is usually
  symmetric, high-frequency predominant and progressive, with variable onset and severity. Human vestibular
  hyperreactivity has been documented in some families. Additional inner hair cell and neuronal degeneration
  may contribute to advanced disease, but its human contribution is unresolved. Hearing aids, implant
  assessment and educational support form clinical care; channel modulators, antisense knockdown and base
  editing remain experimental in the cited studies.
disease_term:
  preferred_term: autosomal dominant nonsyndromic hearing loss 2A
  term:
    id: MONDO:0010817
    label: autosomal dominant nonsyndromic hearing loss 2A
parents:
- nonsyndromic hearing loss
- autosomal dominant disease
- channelopathy
references:
- reference: PMID:20301388
  title: "DFNA2 Nonsyndromic Hearing Loss."
  tags:
  - GeneReviews
- reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader
  title: DFNA2 Nonsyndromic Hearing Loss - GeneReviews&reg; - NCBI Bookshelf
  tags:
  - GeneReviews
inheritance:
- name: Autosomal dominant
  description: >-
    Heterozygous pathogenic KCNQ4 variants usually segregate as autosomal dominant hearing loss, with
    a 50% transmission probability for each child. Most affected individuals have an affected parent;
    the overall de novo proportion is unknown. GeneReviews describes complete penetrance with variable
    onset and severity. Once a familial pathogenic variant is established, prenatal and preimplantation
    genetic testing are possible.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  de_novo_rate: Unknown; most affected individuals have an affected parent
  evidence:
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "DFNA2 nonsyndromic hearing loss is inherited in an autosomal dominant manner."
    explanation: The GeneReviews statement of the inheritance mode.
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Each child of an individual with DFNA2 nonsyndromic hearing loss has a 50% chance of inheriting the KCNQ4 pathogenic variant."
    explanation: >-
      GeneReviews states the transmission risk for a confirmed familial KCNQ4 pathogenic variant; severity
      can vary among relatives.
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Most individuals with DFNA2 nonsyndromic hearing loss have a parent with hearing loss; the proportion of individuals with a de novo KCNQ4 pathogenic variant is unknown."
    explanation: >-
      The source for `de_novo_rate`. The unknown is the source's own statement, not a
      curation gap.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader
    reference_title: DFNA2 Nonsyndromic Hearing Loss - GeneReviews&reg; - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      pathogenic variant exhibit the hearing loss phenotype; onset age and severity are variable.
    explanation: >-
      The full chapter describes penetrance with variable clinical expression.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:20301388
    reference_title: DFNA2 Nonsyndromic Hearing Loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Once the KCNQ4 pathogenic variant has been identified in a family member, prenatal testing for a
      pregnancy at increased risk and preimplantation genetic testing for DFNA2 nonsyndromic hearing loss
      are possible.
    explanation: >-
      Reproductive testing depends on a confirmed familial pathogenic variant.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
pathophysiology:
- name: KCNQ4 Dominant-Negative Subunit Incorporation
  description: >-
    Several pathogenic pore-region variants suppress wild-type Kv7.4 current when coexpressed, consistent
    with dominant-negative interference in tetrameric channels. The strength of suppression and the effect
    of subunit stoichiometry vary by allele. A universal rule that any single mutant subunit completely
    disables every channel is not established for all KCNQ4 variants. Gating defects and dominant-negative
    behavior need not be mutually exclusive.
  biological_scale: MOLECULAR
  genetic_context:
    functional_impact_category: DOMINANT_NEGATIVE
  molecular_functions:
  - preferred_term: voltage-gated potassium channel activity
    term:
      id: GO:0005249
      label: voltage-gated potassium channel activity
    modifier: DECREASED
  downstream:
  - target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
    causal_link_type: DIRECT
    description: >-
      Dominant-negative channel dysfunction reduces the outer hair cell conductance. Null-model evidence
      establishes channel dependence; the exact residual current depends on genotype.
    evidence:
    - reference: PMID:16437162
      reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "KCNQ4 disruption abolished the I(K,n) current of OHCs."
      explanation: Directly connects loss of the channel to loss of the specific outer hair cell conductance it carries.
      directness: INDIRECT
  - target: Inner Hair Cell Degeneration
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Kcnq4 deficiency can be accompanied by later injury to this population. Null-model evidence is indirect
      for dominant-negative human alleles, and intervening processes remain unresolved.
    evidence:
    - reference: PMID:31102762
      reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."
      explanation: The primary observation, and the qualifier that it was seen on a particular genetic background.
      directness: INDIRECT
  - target: Spiral Ganglion Neuron Degeneration
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Kcnq4 deficiency can be accompanied by later injury to this population. Null-model evidence is indirect
      for dominant-negative human alleles, and intervening processes remain unresolved.
    evidence:
    - reference: PMID:31102762
      reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."
      explanation: The primary observation, and the qualifier that it was seen on a particular genetic background.
      directness: INDIRECT
  - target: Prestin Mislocalization
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      KCNQ4 deletion is associated with altered prestin localization; extrapolation to dominant-negative
      human alleles and the intervening process remain uncertain.
    evidence:
    - reference: PMID:40752593
      reference_title: Insights into early cochlear damage induced by potassium channel deficiency.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: >-
        In this study, we demonstrate KCNQ4 deletion disrupts the localization of key proteins like prestin
        and BK channels, alters OHC organization, and induces apoptosis in sensory and SC.
      explanation: >-
        The prestin-localization finding is retained separately from cell-death claims; accompanying findings
        are not treated as proven intervening steps.
  evidence:
  - reference: PMID:21951272
    reference_title: "Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers."
    supports: SUPPORT
    quote_role: PRIMARY_RESULT
    evidence_source: IN_VITRO
    snippet: "Co-expression of wt and KCNQ4 pore mutants suppressed currents to barely detectable levels."
    explanation: >-
      The defining experiment for negative dominance - the mutant subunit suppresses the
      wild-type product rather than merely failing itself. This one is from the paper's
      KEY RESULTS, against the BACKGROUND sentence it is also cited for elsewhere.
  - reference: PMID:10025409
    reference_title: "KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "It abolishes the potassium currents of wild-type KCNQ4 on which it exerts a strong dominant-negative effect."
    explanation: >-
      The original demonstration of negative dominance, from the paper that identified
      KCNQ4 as the DFNA2 gene. The effect is on the wild-type product, which is what
      distinguishes it from haploinsufficiency.
  - reference: PMID:10025409
    reference_title: "KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A mutation in this gene in a DFNA2 pedigree changes a residue in the KCNQ4 pore region."
    explanation: Establishes the pore region as the location of the founding pathogenic variant.
- name: KCNQ4 Haploinsufficiency from Truncating Variants
  description: >-
    Reduced dosage is a proposed mechanism for some human truncating variants, distinct from the strong
    dominant-negative effects of many pore variants. Truncation position does not by itself establish
    nonsense-mediated decay, failed assembly or simple haploinsufficiency. Some early truncating families
    have later, milder hearing loss, but an early severe stop-variant case is also reported. Heterozygous
    null mice have normal hearing in the founding study, limiting a simple cross-species dosage explanation.
    Functional heterozygous assays can help distinguish effects but do not resolve the mechanism of every
    human allele.
  biological_scale: MOLECULAR
  genetic_context:
    functional_impact_category: LOSS_OF_FUNCTION
  molecular_functions:
  - preferred_term: voltage-gated potassium channel activity
    term:
      id: GO:0005249
      label: voltage-gated potassium channel activity
    modifier: DECREASED
  downstream:
  - target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Reduced supply of functional subunits could decrease I(K,n), but the human truncation-to-cochlear-current
      link has not been directly demonstrated in these sources.
    evidence:
    - reference: PMID:23776385
      reference_title: "Genetics of hearing loss: focus on DFNA2."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In deletion mutations, haploinsufficiency has been proposed as the pathogenic mechanism of action.
      explanation: >-
        Review synthesis presents dosage reduction as a proposed mechanism, not a demonstrated property
        of all truncations.
      quote_role: REVIEW_SYNTHESIS
      directness: INDIRECT
  evidence:
  - reference: PMID:23776385
    reference_title: "Genetics of hearing loss: focus on DFNA2."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In deletion mutations, haploinsufficiency has been proposed as the pathogenic mechanism of action.
    explanation: >-
      Review synthesis presents dosage reduction as a proposed mechanism, not a demonstrated property
      of all truncations.
    quote_role: REVIEW_SYNTHESIS
    directness: INDIRECT
  - reference: PMID:23776385
    reference_title: "Genetics of hearing loss: focus on DFNA2."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, the stop codon identified by Hildebrand et al did not fit this phenotype, because the affected
      individual had a more severe form of hearing loss requiring cochlear implantation during childhood.
    explanation: >-
      An exception to the proposed later and milder truncation phenotype.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:23776385
    reference_title: 'Genetics of hearing loss: focus on DFNA2.'
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Those heterozygous for the knockout mutation did not show any hearing abnormalities, suggesting
      that only 50% of currents are required for normal hearing.
    explanation: >-
      Heterozygous knockout animals did not reproduce a simple dosage-related hearing phenotype.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
- name: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
  description: >-
    Kv7.4 mediates the predominant I(K,n) conductance of outer hair cells and contributes to basolateral
    potassium efflux and the resting potential. Complete disruption abolishes this current in knockout
    mice; heterozygous variants can leave residual current, so reduction and complete abolition are distinguished
    by genotype.
  biological_scale: CELLULAR
  cell_types:
  - preferred_term: cochlear outer hair cell
    term:
      id: CL:0000601
      label: cochlear outer hair cell
  biological_processes:
  - preferred_term: potassium ion transmembrane transport
    term:
      id: GO:0071805
      label: potassium ion transmembrane transport
    modifier: DECREASED
  downstream:
  - target: Chronic Outer Hair Cell Depolarization
    causal_link_type: DIRECT
    description: >-
      Without the standing outward potassium current, the cell cannot maintain its
      resting potential and sits depolarised.
    evidence:
    - reference: PMID:16437162
      reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "The ensuing depolarization of OHCs impaired sound amplification."
      explanation: Names depolarization as the direct consequence of losing the conductance, in the same sentence chain as the current measurement.
  evidence:
  - reference: PMID:21951272
    reference_title: "Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers."
    supports: SUPPORT
    quote_role: BACKGROUND
    evidence_source: IN_VITRO
    snippet: "KCNQ4 mediates the predominant K(+) conductance, I(K,n) , of auditory outer hair cells (OHCs), and loss of KCNQ4 function leads to degeneration of OHCs resulting in progressive hearing loss."
    explanation: >-
      Establishes Kv7.4 as the carrier of the predominant outer hair cell conductance
      and links its loss to the downstream degeneration. BACKGROUND: the sentence sits
      in this paper's BACKGROUND AND PURPOSE section, restating what was already known
      before its own patch-clamp experiments.
  - reference: PMID:10025409
    reference_title: "KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Whereas mutations in KCNQ1 cause deafness by affecting endolymph secretion, the mechanism leading to KCNQ4-related hearing loss is intrinsic to outer hair cells."
    explanation: >-
      Locates the lesion inside the hair cell rather than in the fluid environment around
      it. Worth recording explicitly because the sibling channelopathy in the same gene
      family reaches deafness by the opposite route, and the distinction is what makes an
      outer-hair-cell-directed therapy the rational target here.
- name: Chronic Outer Hair Cell Depolarization
  description: >-
    Loss or reduction of I(K,n) depolarizes outer hair cells and can impair their amplification before
    overt degeneration. Mouse and ex-vivo measurements support this functional stage; its reversibility
    and treatment window in people have not been established.
  biological_scale: CELLULAR
  cell_types:
  - preferred_term: cochlear outer hair cell
    term:
      id: CL:0000601
      label: cochlear outer hair cell
  downstream:
  - target: Progressive Outer Hair Cell Degeneration
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Chronic depolarization is proposed to stress outer hair cells and contribute to degeneration. Increased
      calcium entry is a suggested intermediate, not directly established by the cited experiment.
    evidence:
    - reference: PMID:16437162
      reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We conclude that the hearing loss in DFNA2 is predominantly caused by a slow degeneration of OHCs resulting from chronic depolarization."
      explanation: The authors' own causal statement linking depolarization to degeneration.
      directness: INDIRECT
  - target: Progressive High-Frequency Sensorineural Hearing Loss
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Depolarization impairs cochlear amplification before overt cell loss in mice; this provides a functional
      contribution to hearing loss alongside degeneration.
    evidence:
    - reference: PMID:16437162
      reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "The ensuing depolarization of OHCs impaired sound amplification."
      explanation: Records the functional cost of depolarization independently of any cell loss.
  evidence:
  - reference: PMID:16437162
    reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The ensuing depolarization of OHCs impaired sound amplification."
    explanation: Records the functional cost of depolarization independently of any cell loss.
- name: Progressive Outer Hair Cell Degeneration
  description: >-
    Outer hair cell degeneration accompanies progressive hearing loss in multiple Kcnq4 models. Basal
    loss precedes apical loss in some null and missense models, but the p.G322S model initially loses
    apical and middle-turn cells. Expression gradients and phenotype are therefore not a universal spatial
    rule. Inner hair cell and neuronal survival depend on model and observation age.
  biological_scale: TISSUE
  cell_types:
  - preferred_term: cochlear outer hair cell
    term:
      id: CL:0000601
      label: cochlear outer hair cell
  downstream:
  - target: Progressive High-Frequency Sensorineural Hearing Loss
    causal_link_type: DIRECT
    description: >-
      Loss of cochlear amplification contributes to progressive sensorineural hearing loss. The frequency
      pattern varies by model and allele.
    evidence:
    - reference: PMID:16437162
      reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "This progressive hearing loss was paralleled by a selective degeneration of outer hair cells (OHCs)."
      explanation: Couples the time course of hearing loss to the time course of outer hair cell death in the same animals.
  evidence:
  - reference: PMID:16437162
    reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Inner hair cells and their afferent synapses remained mostly intact."
    explanation: Establishes the selectivity of the early degeneration for outer hair cells.
  - reference: PMID:31102762
    reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Cell loss progressed from basal to apical turns with age."
    explanation: The spatial progression that maps onto the high-frequency-first clinical audiogram.
  - reference: PMID:42162447
    reference_title: Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: >-
      Quantitative analysis revealed that, in heterozygous mice, OHC numbers were reduced by 48.9 and
      60.0% in the apical and middle turns, respectively, whereas the basal turn remained largely unaffected.
    explanation: >-
      At four weeks in the G322S model, early loss follows a different spatial pattern from a universal
      basal-first model.
- name: Inner Hair Cell Degeneration
  description: >-
    Inner hair cell loss was observed after outer hair cell degeneration in C3H/HeJ Kcnq4-null mice and
    at high-frequency locations in the humanized p.G228D study. Early preservation in other models does
    not exclude later injury. Mouse age, background and allele complicate comparisons; this is not a demonstrated
    universal second stage in human DFNA2A.
  biological_scale: TISSUE
  cell_types:
  - preferred_term: cochlear inner hair cell
    term:
      id: CL:0000589
      label: cochlear inner hair cell
  downstream:
  - target: Severe-to-profound hearing impairment in later life
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Loss of this auditory cell population is proposed to contribute to severe hearing loss; the cited
      model does not establish its separate quantitative contribution in humans.
    evidence:
    - reference: PMID:31102762
      reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Inner hair cell and spiral ganglion neuron death generates severe hearing loss that could be associated with the last phase of DFNA2."
      explanation: The authors' proposed mapping of this cellular stage onto the late clinical phase, stated as a possibility rather than a demonstration.
      directness: INDIRECT
  evidence:
  - reference: PMID:31102762
    reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."
    explanation: The primary observation, and the qualifier that it was seen on a particular genetic background.
- name: Spiral Ganglion Neuron Degeneration
  description: >-
    Spiral ganglion neuron loss occurs later in the C3H/HeJ knockout study and is also reported in the
    2025 KCNQ4-deficiency study. These observations establish a neuronal component in particular models
    without proving that preceding outer hair cell loss caused it or that all human carriers follow the
    same sequence.
  biological_scale: TISSUE
  cell_types:
  - preferred_term: spiral ganglion neuron
    term:
      id: CL:0011113
      label: spiral ganglion neuron
  downstream:
  - target: Severe-to-profound hearing impairment in later life
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Loss of this auditory cell population is proposed to contribute to severe hearing loss; the cited
      model does not establish its separate quantitative contribution in humans.
    evidence:
    - reference: PMID:31102762
      reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Inner hair cell and spiral ganglion neuron death generates severe hearing loss that could be associated with the last phase of DFNA2."
      explanation: The authors' proposed mapping of this cellular stage onto the late clinical phase, stated as a possibility rather than a demonstration.
      directness: INDIRECT
  evidence:
  - reference: PMID:31102762
    reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."
    explanation: The primary observation, and the qualifier that it was seen on a particular genetic background.
  - reference: PMID:40752593
    reference_title: "Insights into early cochlear damage induced by potassium channel deficiency."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Spiral ganglion neurons (SGNs) also degenerate over time."
    explanation: >-
      An independent report of the neuronal arm of this node, which matters because the
      earlier observation was attributed to one inbred background. Recorded separately
      rather than merged: it does not settle the hypothesis group below, but it removes
      the reading that neuronal loss is a C3H/HeJ artefact alone.
- name: Progressive High-Frequency Sensorineural Hearing Loss
  description: >-
    Symmetric, high-frequency-predominant sensorineural hearing loss commonly progresses to involve all
    frequencies. The clinical course varies by allele and family. GeneReviews describes severe-to-profound
    impairment by age 70 in its summarized cohorts; this is a historical clinical summary rather than
    a prospective guarantee for every newly identified allele.
  biological_scale: ORGANISM
  evidence:
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "DFNA2 nonsyndromic hearing loss is characterized by symmetric, predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive across all frequencies."
    explanation: The GeneReviews definition of the clinical outcome this chain produces.
    quote_role: REVIEW_SYNTHESIS
  downstream:
  - target: Progressive high-frequency sensorineural hearing loss
    causal_link_type: DIRECT
    description: The organism-level hearing deficit is expressed as the clinical audiometric phenotype.
    evidence:
    - reference: PMID:20301388
      reference_title: "DFNA2 Nonsyndromic Hearing Loss."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "DFNA2 nonsyndromic hearing loss is characterized by symmetric, predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive across all frequencies."
      explanation: The GeneReviews definition of the clinical outcome this chain produces.
      quote_role: REVIEW_SYNTHESIS
- name: Prestin Mislocalization
  description: >-
    KCNQ4-deficient mice show altered prestin localization alongside other changes in cochlear organization.
    Prestin is relevant to outer hair cell electromotility, but the cited abstract does not isolate the
    contribution of its mislocalization to hearing loss or establish a human biomarker.
  biological_scale: CELLULAR
  evidence:
  - reference: PMID:40752593
    reference_title: Insights into early cochlear damage induced by potassium channel deficiency.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: >-
      In this study, we demonstrate KCNQ4 deletion disrupts the localization of key proteins like prestin
      and BK channels, alters OHC organization, and induces apoptosis in sensory and SC.
    explanation: >-
      The prestin-localization finding is retained separately from cell-death claims; accompanying findings
      are not treated as proven intervening steps.
mechanistic_hypotheses:
- hypothesis_group_id: late_phase_cellular_target
  hypothesis_label: Outer hair cell degeneration alone accounts for advanced DFNA2A hearing loss
  status: EMERGING
  description: >-
    Outer hair cell degeneration explains much of the hearing deficit in the founding mixed-background
    mice. Expression studies proposed inner hair cell or neuronal involvement, and later null and missense
    models demonstrate additional injury. These findings challenge an exclusively outer-hair-cell account,
    but expression patterns alone do not establish a primary lesion. Age, genotype and background differ
    across studies and have not been isolated as explanations for every discrepancy. The relative contributions
    in human advanced disease remain uncertain; the models do not establish a universal treatment deadline.
  evidence:
  - reference: PMID:16437162
    reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We conclude that the hearing loss in DFNA2 is predominantly caused by a slow degeneration of OHCs resulting from chronic depolarization."
    explanation: >-
      Predominant OHC involvement supports an OHC-centered account; it does not prove strict exclusivity,
      and the full text reports occasional old-animal IHC injury.
    directness: INDIRECT
  - reference: PMID:11042367
    reference_title: "Longitudinal gradients of KCNQ4 expression in spiral ganglion and cochlear hair cells correlate with progressive hearing loss in DFNA2."
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    snippet: "Our data suggest that the primary defect leading to initial high frequency loss and subsequent progressive hearing loss for all frequencies may be due to spiral ganglion and/or IHC dysfunction, rather than an OHC aberration."
    explanation: >-
      Expression-based proposal challenges an exclusive outer-hair-cell account but does not directly
      demonstrate the causal cellular lesion.
    directness: INDIRECT
  - reference: PMID:16207888
    reference_title: "Differential expression of KCNQ4 in inner hair cells and sensory neurons is the basis of progressive high-frequency hearing loss."
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    snippet: "Our expression data suggest that the primary defect leading to high-frequency loss in DFNA2 patients may be attributable to high levels of the dysfunctional Kcnq4_v3 variant in the spiral ganglion and inner hair cells in the basal hook region."
    explanation: >-
      Expression-based proposal challenges an exclusive outer-hair-cell account but does not directly
      demonstrate the causal cellular lesion.
    directness: INDIRECT
  - reference: PMID:31102762
    reference_title: Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model.
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner
      hair cell and spiral ganglion neuron death.
    explanation: >-
      Additional injured populations in this model challenge the exclusive-OHC hypothesis. Human extrapolation
      remains indirect.
    quote_role: PRIMARY_RESULT
    directness: INDIRECT
- hypothesis_group_id: variant_specific_channel_gating
  hypothesis_label: Variant-specific gating and phosphoinositide dependence modify KCNQ4 channel function
  status: EMERGING
  description: >-
    R216H shifts channel activation toward more positive potentials. In a separate heterologous study,
    WT-R331Q forced heteromers respond to PIP2 augmentation or openers, whereas WT-G319D forced heteromers
    are hyperactive and can be downregulated. G319D and R331Q were VUS in that study, so these findings
    describe experimental channel mechanisms rather than established human mechanistic subtypes. Linopirdine
    reduced the hyperactive forced WT-G319D current to the WT-WT level; intracellular poly-L-lysine also
    reduced current. These are in-vitro pharmacology results without demonstrated human benefit.
  evidence:
  - reference: PMID:41639121
    reference_title: Two-step voltage-sensor activation of the human K(V)7.4 channel and effect of a deafness-associated mutation.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Our analysis revealed that R216H impaired the voltage dependence of channel opening and both VSD
      activation components
    explanation: >-
      Voltage-clamp fluorometry in heterologously expressed channels shows altered activation. This does
      not itself demonstrate a dominant-negative mechanism.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:34316018
    reference_title: Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Based on these results, we concluded that p.G319D did not exert a dominant-negative inhibitory effect
      on WT channels
    explanation: >-
      G319D forced heteromers differ from the canonical dominant-negative model. The study's clinical
      classification remained VUS.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:34316018
    reference_title: Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Therefore, we concluded that pathogenic heteromeric WT-p.R331Q channels can be rescued by an increased
      PIP2 concentration, treatment with KCNQ openers, or both.
    explanation: >-
      Experimental rescue result; the authors' word pathogenic in the discussion does not supersede their
      VUS classification table.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:34316018
    reference_title: Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      The known KCNQ inhibitor linopirdine was able to reduce the hyperactive WT-p.G319D-mediated current
      to the WT-WT level
    explanation: >-
      Measured current normalization in the expression system.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
phenotypes:
- category: Auditory
  name: Progressive high-frequency sensorineural hearing loss
  description: >-
    The defining phenotype. Symmetric and predominantly high-frequency at onset, progressing across all
    frequencies. Mild in low frequencies and moderate in high frequencies at younger ages; moderate and
    severe-to-profound respectively in older people. Recognition is often at school age, although high-frequency
    impairment may precede recognition and congenital onset was documented in a W276S family. This timing
    is not universal across alleles.
  phenotype_term:
    preferred_term: High-frequency sensorineural hearing impairment
    term:
      id: HP:0001757
      label: High-frequency sensorineural hearing impairment
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "DFNA2 nonsyndromic hearing loss is characterized by symmetric, predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive across all frequencies."
    explanation: The GeneReviews clinical characterisation.
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:11915881
    reference_title: "Longitudinal and cross-sectional phenotype analysis in a new, large Dutch DFNA2/KCNQ4 family."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: >-
      Persons with this KCNQ4 mutation showed congenital, progressive high-frequency impairment without
      substantial loss of speech recognition during the first decades of life.
    explanation: >-
      A family-specific congenital presentation; not all W276S families have the same reported onset.
- category: Auditory
  name: Severe-to-profound hearing impairment in later life
  description: >-
    Severe-to-profound impairment in later life is described in the GeneReviews cohorts. Age and severity
    vary between families, and the source statement should not be treated as a deterministic prognosis
    for every newly identified allele.
  phenotype_term:
    preferred_term: Progressive sensorineural hearing impairment
    term:
      id: HP:0000408
      label: Progressive sensorineural hearing impairment
    severity: SEVERE
  evidence:
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "By age 70 years, all persons with DFNA2 nonsyndromic hearing loss have severe-to-profound hearing impairment."
    explanation: >-
      Historical GeneReviews summary of late severity; interpreted with the chapter's variable age and
      severity and genotype-specific exceptions.
    quote_role: REVIEW_SYNTHESIS
- category: Vestibular
  name: Vestibular hyperreactivity
  description: >-
    Increased vestibulo-ocular reflex responses were reported in two Dutch DFNA2 families. One W276S family
    had hyperreactivity in 3 of 11 tested individuals, with motion-sickness susceptibility in two. This
    is a human finding, usually subtle, with family-specific ascertainment; it does not establish a general
    vestibular syndrome or a disease-wide frequency. Mouse calyx localization and altered reflexes are
    recorded separately as model evidence.
  phenotype_term:
    preferred_term: Abnormal vestibular function
    term:
      id: HP:0001751
      label: Abnormal vestibular function
  evidence:
  - reference: PMID:11915881
    reference_title: "Longitudinal and cross-sectional phenotype analysis in a new, large Dutch DFNA2/KCNQ4 family."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A hyperactive vestibuloocular reflex was found in 3 of 11 cases: 2 persons were especially susceptible
      to motion sickness.
    explanation: >-
      Direct human vestibular findings in the W276S family; denominator is the tested subset.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:9193215
    reference_title: Inherited nonsyndromic hearing loss. An audiovestibular study in a large family with autosomal dominant progressive hearing loss related to DFNA2.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A significant finding was that 25% to 35% (depending on the exclusion criteria) of the patients
      showed an increased vestibulo-ocular reflex (hyperreactivity) as measured by rotatory responses.
    explanation: >-
      The earlier DFNA2-linked family supplies a second human observation; this predates identification
      of KCNQ4.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
diagnosis:
- name: Audiometry with a characteristic audioprofile
  description: >-
    Diagnosis rests on the shape of the audiogram together with a dominant family
    history, confirmed by finding a heterozygous KCNQ4 pathogenic variant. Annual
    audiometry is the recommended surveillance, since the clinically relevant
    variable is rate of progression rather than a single threshold.
  diagnosis_term:
    preferred_term: audiometric test
    term:
      id: NCIT:C38036
      label: Audiometric Test
  evidence:
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis of DFNA2 nonsyndromic hearing loss is established in an individual with a characteristic audioprofile, a family history consistent with autosomal dominant inheritance, and identification of a heterozygous pathogenic variant in KCNQ4."
    explanation: The GeneReviews diagnostic criteria, naming all three components.
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At least annual audiogram to follow progression of hearing loss."
    explanation: The recommended surveillance interval.
    quote_role: REVIEW_SYNTHESIS
- name: Multigene or genomic testing
  description: >-
    A characteristic audioprofile raises suspicion, but other inherited hearing disorders overlap. Use
    a hearing-loss panel including KCNQ4 or comprehensive genomic testing, with appropriate sequence and
    copy-number assessment. Interpret variants with clinical, segregation and functional evidence; a VUS
    alone is not confirmatory.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader
    reference_title: DFNA2 Nonsyndromic Hearing Loss - GeneReviews&reg; - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      is most likely to identify the genetic cause of the condition while limiting identification of variants
      of uncertain significance and pathogenic variants in genes that do not explain the underlying phenotype.
    explanation: >-
      Full chapter recommends a broader testing strategy rather than reliance on audiogram or single-gene
      testing alone.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
- name: Evaluation of at-risk relatives
  description: >-
    Testing for the established familial pathogenic variant in infancy or early childhood can identify
    relatives who need hearing assessment and support before substantial recognized impairment.
  evidence:
  - reference: PMID:20301388
    reference_title: DFNA2 Nonsyndromic Hearing Loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Determining in infancy or early childhood whether a family member of the proband has inherited a
      pathogenic variant in KCNQ4 allows for early support and management of the child and family.
    explanation: >-
      Early family testing recommendation.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
genetic:
- name: KCNQ4
  association: Causal
  gene_term:
    preferred_term: KCNQ4
    term:
      id: hgnc:6298
      label: KCNQ4
  notes: >-
    KCNQ4 encodes Kv7.4. Dominant-negative pore defects, altered voltage sensing, and proposed dosage
    effects are overlapping mechanistic categories, not an exhaustive partition. W276S is a recurrent
    pathogenic hotspot. Functional gain of current has also been observed, notably for forced WT-G319D
    channels, but the 2021 study classified G319D and R331Q as VUS; cell effects do not establish pathogenicity.
    The 9.5% estimate comes from six KCNQ4 diagnoses among 63 autosomal dominant diagnoses in a 1,119-person
    referred testing cohort, not a worldwide prevalence. Human G321S corresponds to mouse G322S in the
    2026 base-editing study.
  evidence:
  - reference: PMID:42162447
    reference_title: "Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing."
    supports: SUPPORT
    quote_role: BACKGROUND
    evidence_source: HUMAN_CLINICAL
    snippet: "Pathogenic variants in KCNQ4 account for ~9.5% of autosomal dominant nonsyndromic cases."
    explanation: >-
      Secondary background estimate from the 2012–2014 diagnostic cohort; not a population prevalence
      or universal fraction of dominant hearing loss.
  - reference: PMID:40898620
    reference_title: "Antisense oligonucleotide therapy mitigates autosomal dominant progressive hearing loss in a murine model of human DFNA2."
    supports: SUPPORT
    quote_role: BACKGROUND
    evidence_source: HUMAN_CLINICAL
    snippet: "The dominant-negative KCNQ4 p.W276S (c.827G>C) mutation represents a mutational hotspot in DFNA2, yet no effective treatments exist."
    explanation: >-
      Identifies the recurrent variant and states the therapeutic gap this disease
      currently sits in. BACKGROUND for the same reason as the item above - a mouse
      antisense study, and this sentence is its framing rather than its result. The
      human primary source for the hotspot claim is the next item, which carries the
      same claim as a PRIMARY_RESULT.
  - reference: PMID:15699719
    reference_title: "Phenotype determination guides swift genotyping of a DFNA2/KCNQ4 family with a hot spot mutation (W276S)."
    supports: SUPPORT
    quote_role: PRIMARY_RESULT
    evidence_source: HUMAN_CLINICAL
    snippet: "All clinically affected participants were carriers of the W276S hotspot mutation in exon 5 of the KCNQ4 gene on chromosome 1p34."
    explanation: >-
      All clinically affected participants carried W276S in a study of fifteen family members; this does
      not mean all fifteen were affected.
  - reference: PMID:41639121
    reference_title: Two-step voltage-sensor activation of the human K(V)7.4 channel and effect of a deafness-associated mutation.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Our analysis revealed that R216H impaired the voltage dependence of channel opening and both VSD
      activation components
    explanation: >-
      Voltage-clamp fluorometry in heterologously expressed channels shows altered activation. This does
      not itself demonstrate a dominant-negative mechanism.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:35760561
    reference_title: "Proactive functional classification of all possible missense single-nucleotide variants in KCNQ4."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we recorded the whole-cell currents using the patch-clamp technique and categorized 1068 missense SNVs as loss of function, as well as 728 loss-of-function SNVs located in the transmembrane domains"
    explanation: >-
      Large-scale channel-function map provides evidence for interpretation together with other criteria;
      a loss-of-function assay is not a standalone pathogenic classification.
  - reference: PMID:35760561
    reference_title: "Proactive functional classification of all possible missense single-nucleotide variants in KCNQ4."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we coexpressed loss-of-function variants with wild-type KCNQ4 and found 516 variants showed impaired or only partially rescued heterogeneous channel function"
    explanation: >-
      Coexpression tests the effect in the presence of wild-type subunits. Results inform, but do not
      alone determine, human pathogenicity and do not test endogenous splicing.
  - reference: PMID:41639121
    reference_title: Two-step voltage-sensor activation of the human K(V)7.4 channel and effect of a deafness-associated mutation.
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: >-
      The lack of interaction of H216 with E146 meant that the mutation-bearing S4 was less stably anchored,
      indicating that the activated VSD state in the R216H variant is less stable than in WT.
    explanation: >-
      Molecular dynamics supplies a structural interpretation distinct from the experimental gating measurements.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:35760561
    reference_title: Proactive functional classification of all possible missense single-nucleotide variants in KCNQ4.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      After incorporating our patch-clamp data, 40/456 VUSs were reclassified as benign, 47 were likely
      benign, 25 were likely pathogenic, and 344 were still VUSs
    explanation: >-
      Functional evidence contributed to integrated classification; most initially uncertain variants
      remained uncertain.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:34316018
    reference_title: Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Accordingly, p.G319D can be classified as a “variant of uncertain significance (VUS)” based on ACMG/AMP
      guidelines
    explanation: >-
      The primary study did not establish clinical pathogenicity despite the functional phenotype.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:34316018
    reference_title: Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Collectively, the p.R331Q variant was classified as “VUS”
    explanation: >-
      Same clinical-classification limit for the proposed PIP2-sensitive allele.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:26969326
    reference_title: Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: >-
      Patients included in this study were sequentially referred to the Molecular Otolaryngology and Renal
      Research Laboratories (MORL) for clinical genetic testing from January 2012 to September 2014.
    explanation: >-
      This referral cohort supplies the denominator behind the secondary 9.5% claim. Its Table 2 assigns
      six diagnoses to KCNQ4, 9.5% of 63 autosomal dominant molecular diagnoses; this is not population
      prevalence.
  - reference: PMID:41368761
    reference_title: Pathogenic Mechanism of the KCNQ4 Gene Variant in Hearing Loss and Functional Validation in a Zebrafish Model.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: >-
      This study identified a novel KCNQ4 variant, c.825G>T (p.Trp275Cys), associated with progressive
      hereditary hearing loss in a family.
    explanation: >-
      Reported family association for a variant adjacent to W276. The same abstract combines cell experiments
      with structural predictions; it does not justify assigning every structural claim to an experimentally
      established, separate dominant mechanism.
animal_models:
- name: Kcnq4 knockout and dominant-negative knockin mouse
  species: Mouse
  genotype: Kcnq4-/- and Kcnq4 dominant-negative DFNA2 allele knockin
  publication: PMID:16437162
  description: >-
    The founding study compared null animals with a G286S dominant-negative allele, equivalent to human
    G285S. Homozygous null and homozygous dominant-negative animals declined over weeks; heterozygous
    dominant-negative animals declined more slowly over months. Heterozygous null animals showed no hearing
    impairment.
  modeled_mechanisms:
  - target: Chronic Outer Hair Cell Depolarization
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: CELLULAR
    description: >-
      The model establishes the conductance loss and the resulting depolarization by
      direct measurement in the cells concerned.
    limitations: >-
      Mouse cochlear ageing is compressed relative to the human decades-long course,
      so the model reports the mechanism faithfully but not its clinical tempo.
    evidence:
    - reference: PMID:16437162
      reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "It then declined over several weeks in Kcnq4-/- mice and over several months in mice carrying the dominant negative allele."
      explanation: Shows the model reproduces progressive rather than congenital loss, and that the dominant allele is the slower of the two.
  - target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: CELLULAR
    description: Direct electrophysiological measurement of the conductance loss in mutant outer hair cells.
    readouts:
    - name: Outer hair cell I(K,n) current
      target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
      direction: ABOLISHED
      interpretation: The specific conductance carried by Kv7.4 is absent in mutant outer hair cells.
      evidence:
      - reference: PMID:16437162
        reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "KCNQ4 disruption abolished the I(K,n) current of OHCs."
        explanation: The electrophysiological measurement grounding the mechanism.
    evidence:
    - reference: PMID:16437162
      reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "KCNQ4 disruption abolished the I(K,n) current of OHCs."
      explanation: The electrophysiological measurement of the conductance loss.
  - target: Progressive Outer Hair Cell Degeneration
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: TISSUE
    description: Selective outer hair cell loss paralleling the hearing decline.
    evidence:
    - reference: PMID:16437162
      reference_title: "Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "This progressive hearing loss was paralleled by a selective degeneration of outer hair cells (OHCs)."
      explanation: Histological confirmation of the degeneration this node asserts.
- name: Kcnq4 knockout on the C3H/HeJ background
  species: Mouse
  genotype: Kcnq4 knockout backcrossed to C3H/HeJ
  publication: PMID:31102762
  description: >-
    The same null allele on a different inbred background, made specifically to
    look for a mechanism behind the profound late phase that outer hair cell loss
    alone did not explain.
  modeled_mechanisms:
  - target: Inner Hair Cell Degeneration
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: TISSUE
    description: >-
      Demonstrates that inner hair cell and neuronal death occurs, and that it is a
      separate and much later event than outer hair cell loss.
    limitations: >-
      This null model differs from dominant human alleles. Background and age complicate comparison with
      the founding mixed-background study; the cited abstract does not isolate background as the cause
      of discrepant outcomes.
    divergences:
    - divergence_type: POPULATION_MISMATCH
      materiality: QUALIFYING
      description: >-
        This null model differs from dominant human alleles. Background and age complicate comparison
        with the founding mixed-background study; the cited abstract does not isolate background as the
        cause of discrepant outcomes.
    evidence:
    - reference: PMID:31102762
      reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."
      explanation: The observation the model was built to test for.
  - target: Spiral Ganglion Neuron Degeneration
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: TISSUE
    description: >-
      Neuronal counts demonstrate later spiral ganglion loss in the null model.
    readouts:
    - name: Spiral ganglion neuron count
      target: Spiral Ganglion Neuron Degeneration
      direction: DECREASED
      interpretation: Neuronal loss measured directly rather than inferred from threshold shifts.
      evidence:
      - reference: PMID:31102762
        reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."
        explanation: The primary observation, and the qualifier that it was seen on a particular genetic background.
    evidence:
    - reference: PMID:31102762
      reference_title: "Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "In addition to the already reported outer hair cell death, the C3H/HeJ strain also exhibited inner hair cell and spiral ganglion neuron death."
      explanation: The primary observation, and the qualifier that it was seen on a particular genetic background.
- name: Kcnq4 p.W277S knockin mouse
  species: Mouse
  genotype: Kcnq4 p.W277S knockin (homologous to human KCNQ4 p.W276S)
  publication: PMID:40898620
  description: >-
    An allele-specific knockin carrying the mouse equivalent of the recurrent human
    pore hotspot, built as the test bed for allele-preferential antisense knockdown.
  modeled_mechanisms:
  - target: Progressive Outer Hair Cell Degeneration
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: TISSUE
    description: >-
      Reproduces both the progressive hearing loss and the outer hair cell
      degeneration, with the human hotspot allele rather than a null.
    evidence:
    - reference: PMID:40898620
      reference_title: "Antisense oligonucleotide therapy mitigates autosomal dominant progressive hearing loss in a murine model of human DFNA2."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We previously demonstrated that Kcnq4 p.W277S knockin mice harboring the homologous mutation to human KCNQ4 p.W276S recapitulate the progressive hearing loss observed in DFNA2 patients, including the predominant degeneration of OHCs."
      explanation: States the model's fidelity to the human phenotype in the authors' own terms.
      quote_role: BACKGROUND
- name: Kcnq4 p.G228D humanized knock-in mouse
  species: Mouse
  genotype: Kcnq4 humanized homologous p.G228D knock-in, heterozygous and homozygous
  publication: PMID:35599357
  description: >-
    A humanized knock-in carrying the mouse equivalent of a KCNQ4 variant found in a
    large Chinese family, made in both heterozygous and homozygous states. The human
    family carried both genotypes too, so the allele-dose comparison exists on both
    sides.
  modeled_mechanisms:
  - target: Progressive High-Frequency Sensorineural Hearing Loss
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: ORGANISM
    description: >-
      Reproduces the human audiometric trajectory, including the spread from
      mid-and-high frequency loss to all frequencies, and the dose effect between
      heterozygotes and homozygotes.
    limitations: >-
      The mouse timescale is weeks where the human is decades, so the model reproduces
      the sequence and the dose relationship but not the tempo.
    evidence:
    - reference: PMID:35599357
      reference_title: "A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese family."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "The heterozygotes had mid-frequency and high-frequency hearing loss at 4 weeks, and moved toward all frequencies hearing loss at 12 weeks, while the homozygotes had severe-to-profound hearing loss at 8 weeks."
      explanation: >-
        The progression and the allele-dose effect in one measurement. The homozygote
        result is the part the human family also shows, which is unusual for a dominant
        disease and is why the model is worth recording separately.
  - target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: CELLULAR
    description: Reduced potassium current measured in outer hair cells of this allele-specific model.
    readouts:
    - name: Outer hair cell potassium current
      target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
      direction: DECREASED
      interpretation: >-
        Reduced current measured in isolated outer hair cells.
      evidence:
      - reference: PMID:35599357
        reference_title: "A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese family."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "The reduced K+ currents and depolarized resting potentials were revealed in OHCs."
        explanation: Couples the reduced current to the depolarization this entry's chain asserts follows from it.
    evidence:
    - reference: PMID:35599357
      reference_title: "A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese family."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "The reduced K+ currents and depolarized resting potentials were revealed in OHCs."
      explanation: Reduced K+ current in outer hair cells of the p.G228D model.
  - target: Chronic Outer Hair Cell Depolarization
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: CELLULAR
    description: Depolarized resting potential measured in outer hair cells of this allele-specific model.
    readouts:
    - name: Outer hair cell resting membrane potential
      target: Chronic Outer Hair Cell Depolarization
      direction: INCREASED
      interpretation: >-
        Depolarization means a less negative resting voltage, not a decreased voltage.
      evidence:
      - reference: PMID:35599357
        reference_title: "A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese family."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "The reduced K+ currents and depolarized resting potentials were revealed in OHCs."
        explanation: Couples the reduced current to the depolarization this entry's chain asserts follows from it.
    evidence:
    - reference: PMID:35599357
      reference_title: "A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese family."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "The reduced K+ currents and depolarized resting potentials were revealed in OHCs."
      explanation: Depolarized resting potential in outer hair cells of the p.G228D model.
  - target: Progressive Outer Hair Cell Degeneration
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: TISSUE
    description: Basal-to-apical outer hair cell loss in this allele-specific model.
    evidence:
    - reference: PMID:35599357
      reference_title: "A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese family."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "The degeneration of outer hair cells (OHCs) was observed from basal to apical turn of cochlea."
      explanation: Independent confirmation of the spatial progression, in a third mouse model and on a different allele.
- name: kcnq4 morpholino knockdown zebrafish
  species: Zebrafish
  genotype: kcnq4 morpholino knockdown, rescued with wild-type kcnq4 mRNA
  publication: PMID:41368761
  description: >-
    Acute developmental kcnq4 morpholino knockdown produced hair cell, otolith and motor abnormalities.
    Wild-type mRNA rescue supports a gene-related effect but does not exclude every off-target effect.
    This model does not reproduce a dominant-negative human allele or adult cochlear outer hair cell physiology.
    The same paper separately reports a human W275C family and cell/structural studies.
  modeled_mechanisms:
  - target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: TISSUE
    description: >-
      Knocking the channel down reduces hair cell number and disturbs otolith
      morphology, which is consistent with the conductance being required for hair
      cell viability. It is not a measurement of the conductance itself.
    limitations: >-
      Zebrafish have no cochlea and no outer hair cells, so the target node's cell type does not exist
      in this organism; the readouts come from lateral line and inner ear hair cells instead. The knockdown
      is acute and developmental where the human disease is a progressive loss with variable age of onset,
      and morpholino knockdown reduces the whole gene product rather than reproducing a dominant-negative
      allele.
    divergences:
    - divergence_type: SPECIES_MISMATCH
      materiality: QUALIFYING
      description: >-
        The cell type carrying I(K,n) in the human disease - the cochlear outer hair
        cell - has no zebrafish counterpart. The model reports on hair cells generally,
        so it supports the requirement for the channel in hair cell biology and not the
        specific conductance loss this node names.
    - divergence_type: BOUNDARY_OMISSION
      materiality: QUALIFYING
      description: >-
        Negative dominance is outside the model. A morpholino lowers the amount of
        wild-type product; it does not introduce a mutant subunit that poisons tetramers,
        which is the actual lesion in most patients.
    readouts:
    - name: Inner ear hair cell number
      target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
      direction: DECREASED
      interpretation: >-
        Hair cell loss following knockdown, with otolith morphology and motor response
        as the accompanying structural and behavioural measures.
      evidence:
      - reference: PMID:41368761
        reference_title: "Pathogenic Mechanism of the KCNQ4 Gene Variant in Hearing Loss and Functional Validation in a Zebrafish Model."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "This approach revealed significant changes in otolith morphology, a marked reduction in hair cell numbers, and abnormal motor responses."
        explanation: The three measured outcomes of the knockdown.
  evidence:
  - reference: PMID:41368761
    reference_title: "Pathogenic Mechanism of the KCNQ4 Gene Variant in Hearing Loss and Functional Validation in a Zebrafish Model."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We used morpholino to knock down kcnq4 in zebrafish and rescued the phenotype by reintroducing wild-type kcnq4 mRNA."
    explanation: >-
      Wild-type mRNA rescue supports specificity without proving absence of all reagent effects.
- name: Kcnq4-null vestibular mouse
  species: Mouse
  genotype: Kcnq4-/- with or without dominant-negative Kcnq5
  publication: PMID:23408425
  description: >-
    Sensitive reflex testing detected altered vestibulo-ocular responses without circling. Adult KCNQ4
    and KCNQ5 localized to postsynaptic calyx-forming neurons, not vestibular hair cells; this revised
    the localization premise of the older study. Mouse altered reflexes do not establish the direction
    or frequency of human vestibular hyperreactivity.
  evidence:
  - reference: PMID:23408425
    reference_title: Vestibular role of KCNQ4 and KCNQ5 K+ channels revealed by mouse models.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      However, a milder form of vestibular dysfunction was apparent from altered vestibulo-ocular reflexes
      in Kcnq4(-/-)/Kcnq5(dn/dn) and Kcnq4(-/-) mice.
    explanation: >-
      Measured model reflex alteration.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:23408425
    reference_title: Vestibular role of KCNQ4 and KCNQ5 K+ channels revealed by mouse models.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      we now show unambiguously that in adult mice both channels reside in postsynaptic calyx-forming
      neurons, but cannot be detected in the innervated hair cells
    explanation: >-
      Anatomical localization in adult mice, distinct from a human clinical phenotype.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
treatments:
- name: Hearing aids
  description: >-
    Hearing aids support mild-to-moderate hearing loss. GeneReviews reports that amplification commonly
    becomes necessary between ages ten and 40; individual fitting depends on hearing and communication
    needs.
  therapeutic_modality: DEVICE
  evidence:
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Hearing aids for those with mild-to-moderate hearing loss; consideration of cochlear implants when hearing loss is severe to profound"
    explanation: The GeneReviews management recommendation, with the threshold for escalating from amplification to implantation.
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Most affected persons initially require hearing aids to assist with sound amplification between ages ten and 40 years."
    explanation: The age window over which amplification typically becomes necessary.
    quote_role: REVIEW_SYNTHESIS
  treatment_term:
    preferred_term: hearing aid fitting
    term:
      id: NCIT:C15315
      label: Rehabilitation
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: hearing aid
        term:
          id: NCIT:C183182
          label: Hearing Aid
- name: Cochlear implantation
  therapeutic_modality: DEVICE
  description: >-
    Consider cochlear implantation for severe-to-profound hearing loss after assessment. GeneReviews also
    describes hybrid electroacoustic implants when low-frequency hearing remains useful.
  evidence:
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Hearing aids for those with mild-to-moderate hearing loss; consideration of cochlear implants when hearing loss is severe to profound"
    explanation: The GeneReviews management recommendation, with the threshold for escalating from amplification to implantation.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader
    reference_title: DFNA2 Nonsyndromic Hearing Loss - GeneReviews&reg; - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hybrid implants combine two proven technologies – acoustic amplification and implant technology
      – to provide electroacoustic hearing.
    explanation: >-
      Full clinical chapter describes the hybrid option for appropriate residual hearing.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  treatment_term:
    preferred_term: cochlear device implantation and hearing amplification
    term:
      id: NCIT:C15329
      label: Surgical Procedure
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: cochlear implant
        term:
          id: NCIT:C157820
          label: Cochlear Implant
- name: KCNQ Channel Openers
  description: >-
    Experimental retigabine and zinc pyrithione potentiate KCNQ4 current. Homomeric pore mutants and forced
    mutant-containing concatemers can remain unresponsive, while WT-plus-pore-mutant coexpression permits
    restoration of total current, probably through residual wild-type homomers. Failure to repair a mutant
    channel therefore does not prove that a pore-variant carrier cannot benefit. Clinical efficacy is
    not established by these cell experiments. R331Q response is a separate forced-heteromer finding in
    a variant classified as VUS by the source.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: retigabine
      term:
        id: CHEBI:68584
        label: ezogabine
    - preferred_term: zinc pyrithione
      term:
        id: CHEBI:32076
        label: zinc pyrithione
  target_mechanisms:
  - target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
    description: >-
      The openers act on the conductance itself, upstream of depolarization and
      degeneration, which is why they would have to be given before cells are lost.
  evidence:
  - reference: PMID:21951272
    reference_title: "Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The strongest potentiation was observed with a combination of zinc pyrithione plus retigabine."
    explanation: Identifies the drug combination and its effect on the channel.
  - reference: PMID:21951272
    reference_title: "Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers."
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: "DFNA2 mutations located in the channel's pore region abolished channel function and these mutant channels were completely unresponsive to channel openers."
    explanation: >-
      Nonresponse of mutant channels limits direct repair of those channels. It does not refute total-current
      rescue in WT-plus-mutant coexpression or establish a patient exclusion rule.
  - reference: PMID:34316018
    reference_title: "Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Phosphatidylinositol 4,5-bisphosphate (PIP2), an obligatory phospholipid for maintaining KCNQ channel activity, confers differential pharmacological sensitivity of channels to KCNQ openers."
    explanation: >-
      Supplies the reason the response is allele-dependent rather than leaving it as an
      observation - PIP2 dependence differs by domain, so which opener helps depends on
      where the variant sits. This is what makes the strategy genotype-directed rather
      than simply unreliable.
  - reference: PMID:34316018
    reference_title: "Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Loss-of-function variant in the gene encoding the KCNQ4 potassium channel causes autosomal dominant nonsyndromic hearing loss (DFNA2), and no effective pharmacotherapeutics have been developed to reverse channel activity impairment."
    explanation: The standing therapeutic gap this strategy is aimed at, stated by its own investigators.
    quote_role: BACKGROUND
    directness: INDIRECT
  - reference: PMID:21951272
    reference_title: Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In this dominant-negative situation, channel openers essentially restored currents back to wt levels,
      most probably through strong activation of only the small fraction of homomeric wt channels.
    explanation: >-
      Coexpression permits total-current rescue despite unresponsive mutant channels; the study attributes
      this probably to wild-type homomers.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: Allele-Preferential Antisense Oligonucleotide Knockdown
  description: >-
    ASO-123 is a 2′-MOE-wing/DNA-gap RNase H gapmer with a phosphorothioate backbone and 5-methylcytosine.
    In W277S heterozygous mice, a 15-μg round-window injection at P1–P3 preferentially reduced mutant
    transcript and partially improved hearing, outer hair cell survival and physiology through seven weeks.
    Preference is dose dependent: 30 μg also reduced wild-type transcripts and reduced pup survival. Benefit
    was incomplete and declined with time; neonatal mouse delivery does not establish efficacy, dosing
    or a treatment window in people. Human W276S selectivity was tested separately in transfected cells.
  therapeutic_modality: ANTISENSE_OLIGONUCLEOTIDE
  oligonucleotide_details:
    oligonucleotide_mechanism: RNASE_H_KNOCKDOWN
    target_gene:
      preferred_term: KCNQ4
      term:
        id: hgnc:6298
        label: KCNQ4
    target_transcript: mutant KCNQ4 mRNA (p.W276S allele)
    oligonucleotide_chemistry: TWO_PRIME_O_METHOXYETHYL
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_mechanisms:
  - target: KCNQ4 Dominant-Negative Subunit Incorporation
    description: >-
      Removing the mutant transcript prevents the poisoned subunit being made at all,
      which is the most upstream point in this chain that a therapy can act on.
  evidence:
  - reference: PMID:40898620
    reference_title: "Antisense oligonucleotide therapy mitigates autosomal dominant progressive hearing loss in a murine model of human DFNA2."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In a Kcnq4 p.W277S knockin mouse model mimicking DFNA2, ASO-123 preferentially suppressed mutant transcripts, attenuated progressive hearing loss, and improved outer hair cell survival while enhancing their electrophysiologic function."
    explanation: The in vivo efficacy result, covering transcript selectivity, hearing, cell survival and function.
  - reference: PMID:40898620
    reference_title: "Antisense oligonucleotide therapy mitigates autosomal dominant progressive hearing loss in a murine model of human DFNA2."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In a systemic in vitro screen, ASO-123 demonstrated a knockdown of mutant Kcnq4 while preserving wild-type transcripts."
    explanation: Establishes allele preference, which is the property the whole strategy depends on.
  - reference: PMID:40898620
    reference_title: Antisense oligonucleotide therapy mitigates autosomal dominant progressive hearing loss in a murine model of human DFNA2.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Unexpectedly, although pups subjected to the 15 μg ASO-123 and 30 μg NT-ASO injections exhibited
      comparable survival rates with non-injected pups, the 30 μg ASO-123 injections significantly reduced
      survival.
    explanation: >-
      Primary dose-limiting animal safety finding.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:40898620
    reference_title: Antisense oligonucleotide therapy mitigates autosomal dominant progressive hearing loss in a murine model of human DFNA2.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In contrast, although WT transcript levels were significantly reduced by 51.81% in the ASO-123 30-μg
      group compared with untreated mice, there was no significant change in the ASO-123 15-μg group.
    explanation: >-
      Allele preference depends on dose; sparing is not absolute.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:40898620
    reference_title: Antisense oligonucleotide therapy mitigates autosomal dominant progressive hearing loss in a murine model of human DFNA2.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      At 7 weeks, we observed a significant deceleration of the expected progressive hearing loss with
      10.06–15.91 dB SPL improvements in the ABR thresholds to all click and tone stimuli.
    explanation: >-
      Partial hearing benefit after neonatal delivery, not normalization.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: Adenine Base Editing of the Pathogenic Allele
  description: >-
    Dual AAV-ie split-ABE8e was delivered through the posterior semicircular canal at P2–P3 to mice carrying
    Kcnq4 G322S, equivalent to human G321S. The often-quoted 21.4–28.9% DNA correction was measured in
    bulk organ of Corti from homozygotes at three weeks; heterozygous baseline-adjusted DNA values were
    7.9–16.7%. These are not percentages of corrected outer hair cells. In heterozygotes, the lower dose
    sustained partial hearing benefit to 32 weeks, with maximal 49.09-dB threshold improvement at 32 kHz
    at 20 weeks. Higher dose gave faster early improvement but earlier later deterioration. Cochlear inflammation,
    increased RNA A-to-I editing and systemic editor exposure limit a blanket safety claim. Human G321S
    correction was demonstrated in cells; clinical efficacy remains unestablished.
  therapeutic_modality: GENE_EDITING
  treatment_term:
    preferred_term: Gene Therapy
    term:
      id: NCIT:C15238
      label: Gene Therapy
  target_mechanisms:
  - target: KCNQ4 Dominant-Negative Subunit Incorporation
    description: >-
      Correction restores wild-type sequence in a fraction of alleles; residual mutant expression and
      unedited cells remain.
  evidence:
  - reference: PMID:42162447
    reference_title: "Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Treatment reduced auditory brainstem response thresholds by up to 49.09 dB SPL at optimal frequencies, mitigated degeneration of hair cells, spiral ganglion neurons, and auditory nerve fibers, and partially restored outer hair cell electrophysiology."
    explanation: The efficacy result across function, histology and electrophysiology.
  - reference: PMID:42162447
    reference_title: "Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "A dose-dependent therapeutic window emerged: higher doses promoted rapid recovery, whereas optimized lower doses minimized long-term toxicity and sustained functional benefit for at least 32 weeks."
    explanation: The safety finding, which is the part that constrains translation rather than supporting it.
  - reference: PMID:42162447
    reference_title: Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      At the transcriptomic level, RNA-seq analysis identified an increase in A-to-I RNA editing events
      in the cochlea following AAV_ABE8e_N + C_322 administration
    explanation: >-
      Off-target RNA editing remains relevant despite reassuring tested DNA endpoints.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:42162447
    reference_title: Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Notably, the extent of cytokine/chemokine upregulation and macrophage accumulation was greater in
      the high-dose group than in the low-dose group
    explanation: >-
      Local inflammation and dose effects constrain safety and durability.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: School support and hearing surveillance
  description: >-
    Provide educational assistance where needed, obtain at least annual audiograms and encourage avoidance
    of loud noise. These recommendations accompany individualized amplification and implant assessment.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader
    reference_title: DFNA2 Nonsyndromic Hearing Loss - GeneReviews&reg; - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      For school-age children or adolescents, special assistance for the hearing impaired may be warranted
      and, where available, should be offered.
    explanation: >-
      Educational support from the full chapter.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader
    reference_title: DFNA2 Nonsyndromic Hearing Loss - GeneReviews&reg; - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Audiograms should be obtained on an annual basis to follow progression of hearing loss.
    explanation: >-
      Disease-specific surveillance interval.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader
    reference_title: DFNA2 Nonsyndromic Hearing Loss - GeneReviews&reg; - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Avoiding exposure to loud noise may reduce the rate of progression of high-frequency SNHL.
    explanation: >-
      Clinical precaution; not proof of a genotype-specific noise interaction.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
- name: Genetic counseling
  description: >-
    Discuss variable severity, 50% transmission risk, testing of relatives and reproductive testing once
    the familial pathogenic variant is established.
  treatment_term:
    preferred_term: Genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Each child of an individual with DFNA2 nonsyndromic hearing loss has a 50% chance of inheriting the KCNQ4 pathogenic variant."
    explanation: >-
      GeneReviews states the transmission risk for a confirmed familial KCNQ4 pathogenic variant; severity
      can vary among relatives.
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:20301388
    reference_title: DFNA2 Nonsyndromic Hearing Loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Once the KCNQ4 pathogenic variant has been identified in a family member, prenatal testing for a
      pregnancy at increased risk and preimplantation genetic testing for DFNA2 nonsyndromic hearing loss
      are possible.
    explanation: >-
      Reproductive testing depends on a confirmed familial pathogenic variant.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
environmental:
- name: Loud noise exposure
  description: >-
    Noise is an aggravating exposure rather than a cause. GeneReviews lists avoiding
    loud noise under agents and circumstances to avoid, on the reasoning that it may
    slow the rate of high-frequency progression. The mechanistic rationale is that
    noise damages the same outer hair cells the channel defect is already killing, so
    the two insults share a target.
  exposure_term:
    preferred_term: exposure to sound radiation
    term:
      id: ECTO:8000044
      label: exposure to sound radiation
  influences_mechanisms:
  - target: Progressive Outer Hair Cell Degeneration
    environmental_effect: EXACERBATES
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Noise exposure is expected to add to the outer hair cell loss the channel
      defect produces. The link is indirect: the source states the clinical
      recommendation and the expected effect on progression rate, not a measured
      interaction in DFNA2A cochleae.
    evidence:
    - reference: PMID:20301388
      reference_title: "DFNA2 Nonsyndromic Hearing Loss."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Avoiding exposure to loud noise may reduce the rate of progression of high-frequency SNHL."
      explanation: >-
        The GeneReviews avoidance recommendation. Note the hedge in the source - "may
        reduce" - which is why the interaction is recorded as expected rather than
        demonstrated.
      quote_role: REVIEW_SYNTHESIS
    - reference: PMID:40752593
      reference_title: "Insights into early cochlear damage induced by potassium channel deficiency."
      supports: REFUTE
      evidence_source: MODEL_ORGANISM
      snippet: "Despite these structural changes, noise exposure does not exacerbate OHC damage in our KCNQ4-deficient model."
      explanation: >-
        The only experiment here that tests the interaction rather than assuming it, and
        it comes out against. A KCNQ4-deficient mouse exposed to noise showed no added
        outer hair cell damage. This does not overturn the clinical recommendation, which
        rests on general noise ototoxicity in an already-compromised cochlea, but it is
        the reason the edge stays INDIRECT_UNKNOWN_INTERMEDIATES rather than being
        upgraded on the strength of a plausible shared target.
  evidence:
  - reference: PMID:20301388
    reference_title: "DFNA2 Nonsyndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Agents/circumstances to avoid: Avoiding exposure to loud noise may reduce the rate of progression of high-frequency SNHL."
    explanation: The full GeneReviews avoidance statement including its section heading.
    quote_role: REVIEW_SYNTHESIS
- name: Aminoglycoside antibiotic exposure
  description: >-
    Aminoglycosides inhibit I(K,n) in isolated wild-type rat outer hair cells through reduced PIP2 availability.
    This provides a mechanistic convergence with KCNQ4 loss of function, but the cited study did not test
    increased drug susceptibility in DFNA2A carriers or a mutant model. A genotype-specific second hit
    remains an inference.
  exposure_term:
    preferred_term: exposure to aminoglycoside antibiotic
  review_notes: >-
    Left unbound deliberately, and the reason is worth recording because it is not the
    usual one. ECTO does have an exact term - ECTO:9002231, "exposure to aminoglycoside
    antibiotic" - and it resolves in OLS. It does not resolve in the sqlite:obo:ecto
    build that conf/oak_config.yaml routes the ECTO prefix to, where the CURIE returns a
    null label, so binding it fails just validate-terms with both "not in dynamic enum
    ExposureTerm" and "not found in ontology". Searching that build for an alternative
    returns only pesticide and acaricide exposures, none of which is this. So the term
    exists, is correct, and cannot be used until the configured adapter catches up.
    Filed as a separate issue; the free-text preferred_term is the accurate interim.
  influences_mechanisms:
  - target: Loss of the Outer Hair Cell I(K,n) Potassium Conductance
    environmental_effect: EXACERBATES
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      The intermediate is known and named - PIP2 depletion - which is why this is
      INDIRECT_KNOWN_INTERMEDIATES rather than unknown. The exposure acts on the same
      node the genetic lesion acts on, one step removed.
    evidence:
    - reference: PMID:20935082
      reference_title: "Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The inhibition results from PI(4,5)P₂ depletion indicated by fluorescence imaging of cellular
        PI(4,5)P₂ and the dependence of inhibition on PI(4,5)P₂ availability and on PI(4,5)P₂ affinity
        of recombinant KCNQ channels.
      explanation: >-
        The measured inhibition is attributed to PIP2 depletion in wild-type-cell experiments. This is
        indirect evidence for an interaction with DFNA2A genotype.
      directness: INDIRECT
  evidence:
  - reference: PMID:20935082
    reference_title: "Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "OHC survival critically depends on a specific K+ conductance (I(K,n)) mediated by KCNQ4 (Kv7.4) channels."
    explanation: >-
      States the dependence that makes the exposure and the genotype converge - outer
      hair cell survival rests on the same conductance both of them reduce.
    quote_role: BACKGROUND
  - reference: PMID:20935082
    reference_title: "Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      As a common hallmark of all KCNQ isoforms, channel activity requires phosphatidylinositol(4,5)bisphosphate
      [PI(4,5)P₂].
    explanation: >-
      The complete cached chemical formula and sentence establish the PIP2 requirement.
    quote_role: BACKGROUND
discussions:
- discussion_id: dfna2a_prevalence_unquantified
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - disease#Autosomal Dominant Nonsyndromic Hearing Loss 2A
  prompt: >-
    What is the prevalence or incidence of DFNA2A, as distinct from its share of
    autosomal dominant nonsyndromic hearing loss?
  rationale: >-
    The cited 9.5% figure is six of 63 autosomal dominant molecular diagnoses in a referred testing cohort,
    not a population denominator. Rare missense carrier frequency also cannot be substituted for disease
    prevalence because many variants have uncertain or benign consequences. A population-based estimate
    was not identified in the reviewed sources.
  evidence:
  - reference: PMID:42162447
    reference_title: "Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing."
    supports: SUPPORT
    directness: INDIRECT
    quote_role: BACKGROUND
    evidence_source: HUMAN_CLINICAL
    snippet: "Pathogenic variants in KCNQ4 account for ~9.5% of autosomal dominant nonsyndromic cases."
    explanation: >-
      The background fraction derives from a diagnostic cohort and does not measure population prevalence.
  - reference: PMID:35760561
    reference_title: "Proactive functional classification of all possible missense single-nucleotide variants in KCNQ4."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: COMPUTATIONAL
    snippet: "approximately one in 100 people harbors missense variants in KCNQ4 (missense variants with minor allele frequency > 0.1% were excluded), but most are of unknown consequence"
    explanation: >-
      Why a carrier-frequency figure cannot be substituted for a prevalence here. One
      person in a hundred carries a rare KCNQ4 missense variant and the great majority
      of those variants have no established consequence, so the population burden of
      the disease cannot be read off the allele data.
    quote_role: BACKGROUND
notes: >-
  This entry covers KCNQ4-related DFNA2A. GJB3/DFNA2B is curated separately, but the GeneReviews chapter
  challenges the evidence for GJB3-related dominant hearing loss; sharing the historical DFNA2 locus designation
  does not establish an equally supported second cause. Hearing aids, cochlear implant assessment, counseling
  and educational support are clinical care. Molecular interventions listed here are experimental in the
  cited cell and animal studies.

📚

References & Deep Research

References

2

PMID:20301388

DFNA2 Nonsyndromic Hearing Loss.

No top-level findings curated for this source.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK1209/?report=reader

DFNA2 Nonsyndromic Hearing Loss - GeneReviews® - NCBI Bookshelf

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: Autosomal_Dominant_Nonsyndromic_Hearing_Loss_2A (MONDO:0010817) · 2026-09-13T21:44:32Z · View source

De novo curation of DFNA2A, the KCNQ4 half of the DFNA2 locus. Deep research: one openscientist report, committed alongside the entry. Report reference validation resolved 13/13 citations with confabulation_rate 0.0 and 15/15 quotes valid; term validation returned needs_review: true on 2 label mismatches, both table-parsing artefacts rather than wrong bindings. just preflight-dr returns PASS with OMIM agreement (600101 on both sides). GeneReviews baseline: PMID:20301388 (DFNA2 Nonsyndromic Hearing Loss) fetched, tagged in the top-level references block, and used for the clinical characterisation, diagnosis, management and agents-to-avoid content. The entry is curated as a separate Disease from Autosomal_Dominant_Nonsyndromic_Hearing_Loss_2B (GJB3) because the two share a locus designation but not a mechanism. A mechanistic_hypotheses block records the live disagreement about which cochlear cell type accounts for the late profound phase, with SUPPORT and REFUTE evidence curated on both sides from the founding mouse model, two expression studies, and the C3H/HeJ backcross. Three animal models are linked with modeled_mechanisms and readouts. Four treatments span amplification, KCNQ channel openers, allele-preferential antisense oligonucleotide knockdown and adenine base editing; three of the four are preclinical and each is marked as such. One term error of my own was caught by just validate-terms: HP:0001751 written from memory as 'Abnormality of the vestibular system' is 'Abnormal vestibular function'. Separately, the aminoglycoside exposure could not be bound: ECTO:9002231 is exact and resolves in OLS but returns a null label in the sqlite:obo:ecto build the config routes ECTO to, so the exposure_term carries a free-text preferred_term and a review_notes block; filed as issue #11795. Validation: schema, term and reference checks pass with 53/53 snippets verified; check-entity-refs, check-causal-targets, check-duplicate-keys, check-qualifier-terms and check-enum-values all pass.

OpenScientist ▸

Autosomal Dominant Nonsyndromic Hearing Loss 2A (DFNA2A): Comprehensive Disease Characteristics Report

openscientist-autonomous 12 citations 2026-09-13T21:37:31.470576

Autosomal Dominant Nonsyndromic Hearing Loss 2A (DFNA2A): Comprehensive Disease Characteristics Report

Disease: Autosomal Dominant Nonsyndromic Hearing Loss 2A (DFNA2A) MONDO ID: MONDO:0010817 OMIM: #600101 Causal gene: KCNQ4 (Kv7.4), chromosome 1p34.2 (HGNC:6298; OMIM 603537; NCBI Gene 9132; UniProt P56696) Category:* Mendelian, monogenic potassium channelopathy

Evidence-source key: [H] human clinical/genetic · [M] model organism · [V] in vitro/electrophysiology · [C] computational/structural.

Summary

Autosomal Dominant Nonsyndromic Hearing Loss 2A (DFNA2A) is a monogenic sensorineural hearing loss caused by heterozygous pathogenic variants in KCNQ4, the gene encoding the voltage-gated potassium channel Kv7.4. Kv7.4 generates the standing potassium conductance (I_K,n) that permits potassium efflux across the basolateral membrane of cochlear outer hair cells (OHCs). Its dysfunction — through either dominant-negative pore mutations (typified by the recurrent p.W276S hotspot) or haploinsufficiency-inducing truncations — chronically depolarizes OHCs and burdens them with potassium and calcium overload, driving a stereotyped basal-to-apical wave of outer hair cell degeneration that later extends to inner hair cells and spiral ganglion neurons. Clinically this manifests as bilateral, symmetric, progressive, high-frequency-onset sensorineural hearing loss with age-dependent penetrance, beginning in childhood or early adulthood and worsening across the lifespan. KCNQ4 accounts for approximately 9.5% of autosomal dominant nonsyndromic hearing loss, making it one of the leading genes in this class.

The original identification of KCNQ4 by Kubisch and colleagues in 1999 established the gene's outer-hair-cell expression and its dominant-negative disease mechanism. Subsequent human genetic, mouse-model, and in vitro electrophysiological studies have refined a coherent causal chain — from channel loss to ionic dysregulation to spatially ordered hair-cell death — and have revealed a critical dependence of channel activity on the membrane lipid PIP2, which mechanistically links KCNQ4 biology to aminoglycoside ototoxicity. This PIP2 dependence exemplifies a gene-environment interaction relevant to disease susceptibility and progression.

Management remains supportive: hearing aids in early stages and cochlear implantation in advanced disease. No approved pharmacotherapy exists. However, three mechanism-matched therapeutic strategies now show durable preclinical rescue: PIP2/channel-modulating small molecules for loss-of-function variants, allele-selective antisense oligonucleotides (ASO-123) that suppress the mutant p.W276S transcript while sparing wild-type, and AAV-delivered adenine base editing (ABE8e) that directly corrects the pathogenic DNA and restores auditory function for at least 32 weeks. Because rescue is effective only while cochlear cells remain viable, these approaches define a therapeutic critical window before irreversible hair-cell and neuronal loss.

Key Findings

Finding 1 — DFNA2A is caused by dominant KCNQ4 (Kv7.4) potassium channel mutations acting on outer hair cells [H][V]

The foundational discovery came from Kubisch et al. (1999), who cloned KCNQ4 as a novel member of the KCNQ voltage-gated potassium channel family, mapped it to the DFNA2 locus at chromosome 1p34, and showed that in the cochlea it is expressed specifically in the sensory outer hair cells. In a DFNA2 pedigree they identified a mutation altering a residue in the KCNQ4 pore region that abolishes the potassium currents of wild-type KCNQ4 on which it exerts a strong dominant-negative effect. This established both the causal gene and the dominant-negative disease mechanism.

Critically, this distinguishes KCNQ4 pathology from that of its relative KCNQ1. Whereas KCNQ1 mutations disrupt endolymph secretion in the stria vascularis, KCNQ4 pathology is intrinsic to the outer hair cells themselves — a defect in cell-autonomous potassium handling rather than in the composition of the surrounding fluid.

"We have now cloned KCNQ4, a novel member of this branch. It maps to the DFNA2 locus for a form of nonsyndromic dominant deafness. In the cochlea, it is expressed in sensory outer hair cells. A mutation in this gene in a DFNA2 pedigree changes a residue in the KCNQ4 pore region. It abolishes the potassium currents of wild-type KCNQ4 on which it exerts a strong dominant-negative effect." — PMID: 10025409

Finding 2 — KCNQ4 p.W276S is a mutational hotspot, and two mechanistic classes of variants exist [H][V]

Two distinct mechanistic classes of pathogenic KCNQ4 variant are recognized: (1) dominant-negative missense variants in the pore region, which poison the tetrameric channel and abolish current even when wild-type subunits are present, and (2) truncating/haploinsufficiency variants, which reduce functional channel dosage. The dominant-negative class produces the most severe phenotypes because a single mutant subunit incorporated into the heterotetramer disables the whole channel.

The p.W276S (c.827G>C) missense variant in exon 5 is a recurrent mutational hotspot in DFNA2. Topsakal et al. (2005) confirmed that all clinically affected participants in a studied cohort carried the W276S hotspot mutation, producing autosomal dominant progressive sensorineural hearing impairment. Jang et al. (2025) reaffirmed the dominant-negative nature and hotspot status of this variant. Population-level genetic data indicate that pathogenic KCNQ4 variants account for approximately 9.5% of autosomal dominant nonsyndromic cases.

"All clinically affected participants were carriers of the W276S hotspot mutation in exon 5 of the KCNQ4 gene on chromosome 1p34." — PMID: 15699719

"The dominant-negative KCNQ4 p.W276S (c.827G>C) mutation represents a mutational hotspot in DFNA2" — PMID: 40898620

"Pathogenic variants in KCNQ4 account for ~9.5% of autosomal dominant nonsyndromic cases." — PMID: 42162447

Finding 3 — Causal chain: KCNQ4 loss → OHC potassium overload/depolarization → basal-to-apical hair cell then neuron degeneration [M][V]

The spatiotemporal pattern of degeneration is one of the best-established features of DFNA2A pathophysiology. In a Kcnq4 knockout mouse on the C3H/HeJ background, Carignano et al. (2019) found that outer hair cell death was already present by week 3, whereas inner hair cell and spiral ganglion neuron loss started roughly 30 weeks later. Importantly, the kinetics of OHC loss slowed from the basal to the apical cochlear regions, correlating with the wild-type basal-to-apical gradient of KCNQ4 expression — a strong mechanistic link between where the channel is most needed and where cells die first.

This pattern is recapitulated in a humanized knock-in model. Cui et al. (2022) engineered a human p.G228D mutation and observed progressive OHC degeneration proceeding from the basal to the apical turn of the cochlea. Underlying this cell death is the loss of the KCNQ4-mediated standing conductance: Leitner et al. (2011) established that OHC survival critically depends on I_K,n, and that dysfunction or genetic ablation of KCNQ4 results in OHC degeneration and deafness in both mouse and human. Without this conductance, OHCs cannot extrude potassium entering through apical mechanotransduction channels; they remain chronically depolarized and accumulate potassium (and, secondarily, calcium), triggering degeneration.

"While for outer hair cells it was already present by week 3, inner hair cell and neuronal loss started 30 weeks later. We also established that outer hair cell loss kinetics slowed down from basal to apical regions correlating with KCNQ4 expression pattern determined in wild-type mice." — PMID: 31102762

"The degeneration of outer hair cells (OHCs) was observed from basal to apical turn of cochlea." — PMID: 35599357

"OHC survival critically depends on a specific K+ conductance (I(K,n)) mediated by KCNQ4 (Kv7.4) channels. Dysfunction or genetic ablation of KCNQ4 results in OHC degeneration and deafness in mouse and humans." — PMID: 20935082

Finding 4 — Emerging genotype/mechanism-based therapeutics: PIP2 modulation, allele-selective ASOs, and base editing [M][V]

Three distinct, mechanism-matched therapeutic strategies have demonstrated preclinical efficacy, each aligned to a different class of variant:

PIP2/channel modulation — Lee et al. (2021) characterized loss-of-function KCNQ4 variants across different functional domains and proposed PIP2 (phosphatidylinositol 4,5-bisphosphate)-based pharmacotherapy to restore impaired channel activity, matched to the mechanism of the specific variant. They emphasized that no effective pharmacotherapeutics had yet been developed to reverse channel activity impairment.

Allele-selective antisense oligonucleotides — Jang et al. (2025) developed ASO-123, an allele-preferential antisense oligonucleotide that selectively knocked down the mutant Kcnq4 p.W276S transcript while preserving wild-type transcripts. In a p.W277S knock-in mouse model mimicking DFNA2, ASO-123 attenuated progressive hearing loss and improved outer hair cell survival while enhancing electrophysiological function.

Adenine base editing — Kong et al. (2026) used dual-AAV delivery of the adenine base editor ABE8e to correct the human KCNQ4 c.961G>A (p.G321S) mutation, achieving 21.4–28.9% correction in the organ of Corti — the highest efficiency reported for genetic hearing loss — reducing auditory brainstem response thresholds by up to 49.09 dB SPL at optimal frequencies, with durable benefit lasting at least 32 weeks.

"In a Kcnq4 p.W277S knockin mouse model mimicking DFNA2, ASO-123 preferentially suppressed mutant transcripts, attenuated progressive hearing loss, and improved outer hair cell survival while enhancing their electrophysiologic function." — PMID: 40898620

"Dual-AAV delivery of the adenine base editor ABE8e achieved 21.4-28.9% correction in the organ of Corti-the highest efficiency reported for genetic hearing loss... Treatment reduced auditory brainstem response thresholds by up to 49.09 dB SPL at optimal frequencies" — PMID: 42162447

"Loss-of-function variant in the gene encoding the KCNQ4 potassium channel causes autosomal dominant nonsyndromic hearing loss (DFNA2), and no effective pharmacotherapeutics have been developed to reverse channel activity impairment." — PMID: 34316018

Finding 5 — Phenotype is bilateral, symmetric, progressive high-frequency-onset SNHL with age-dependent penetrance; genotype scales severity [H][M]

The DFNA2A phenotype is a bilateral, symmetric, progressive sensorineural hearing loss that begins in the high frequencies and extends to all frequencies over time. Topsakal et al. (2005) documented that all clinically affected W276S carriers showed autosomal dominant progressive sensorineural hearing impairment, with refined phenotypic features confirming previously described DFNA2 phenotypes.

The humanized p.G228D mouse of Cui et al. (2022) provides direct evidence that variant dosage scales severity: heterozygotes had mid- and high-frequency hearing loss at 4 weeks that progressed toward all-frequency loss by 12 weeks, whereas homozygotes reached severe-to-profound hearing loss by 8 weeks. This gene-dosage relationship parallels the human observation that dominant-negative variants (functionally more damaging than loss-of-function alleles) tend to produce earlier and more severe disease.

"Refined phenotypic features confirmed previously described phenotypes of DFNA2 families." — PMID: 15699719

"The heterozygotes had mid-frequency and high-frequency hearing loss at 4 weeks, and moved toward all frequencies hearing loss at 12 weeks, while the homozygotes had severe-to-profound hearing loss at 8 weeks." — PMID: 35599357

Finding 6 — KCNQ4 activity is PIP2-dependent, linking genetic loss to aminoglycoside ototoxicity (gene-environment interaction) [V]

Leitner et al. (2011) established that channel activity of all KCNQ isoforms, including KCNQ4, requires the membrane phospholipid PIP2 [PI(4,5)P2]. They further showed that aminoglycoside antibiotics deplete PIP2, thereby inhibiting I_K,n, depolarizing OHCs, and — notably — that the PIP2-sequestration potency of individual aminoglycosides correlates with their known clinical ototoxicity ranking. This provides a molecular explanation for aminoglycoside-induced hearing loss and, importantly, a gene-environment interaction: individuals with partially compromised KCNQ4 function (from a pathogenic variant) may have reduced physiological reserve and heightened vulnerability to PIP2-depleting ototoxic insults.

"OHC survival critically depends on a specific K+ conductance (I(K,n)) mediated by KCNQ4 (Kv7.4) channels. Dysfunction or genetic ablation of KCNQ4 results in OHC degeneration and deafness in mouse and humans. As a common hallmark of all KCNQ isoforms, channel activity requires phosphatidylinositol(4,5)bisphosphate [PI(4,5)P₂]." — PMID: 20935082

Finding 7 — DFNA2A is autosomal dominant with age-dependent penetrance; KCNQ4 is a leading ADNSHL gene treatable within a hair-cell survival window [H][M]

DFNA2A is inherited in an autosomal dominant pattern with age-dependent penetrance: hearing loss may be mild or subclinical in childhood and only becomes fully manifest with age, progressing from mild high-frequency loss to profound loss across all frequencies. Kong et al. (2026) confirmed that pathogenic KCNQ4 variants account for ~9.5% of autosomal dominant nonsyndromic hearing loss and demonstrated that genetic correction mitigated degeneration of hair cells, spiral ganglion neurons, and auditory nerve fibers, and partially restored outer hair cell electrophysiology — but only while the cochlear cells remained viable. This defines a therapeutic critical window: intervention must occur before irreversible cell loss.

"Pathogenic variants in KCNQ4 account for ~9.5% of autosomal dominant nonsyndromic cases." — PMID: 42162447

"mitigated degeneration of hair cells, spiral ganglion neurons, and auditory nerve fibers, and partially restored outer hair cell electrophysiology" — PMID: 42162447

Report by Requested Sections

1. Disease Information

DFNA2A is a nonsyndromic (isolated, no associated systemic features) autosomal dominant form of progressive sensorineural hearing loss. "Nonsyndromic" indicates the hearing loss occurs without additional clinical features such as vestibular dysfunction, retinal disease, or renal anomalies that would define a syndrome.

Key identifiers:

Resource	Identifier
MONDO	MONDO:0010817
OMIM (phenotype)	#600101 (DFNA2A)
Gene (OMIM)	KCNQ4 *603537
HGNC	KCNQ4 (HGNC:6298)
NCBI Gene	9132
UniProt	P56696
Locus	DFNA2, chromosome 1p34.2
ICD-10	H90.5 (sensorineural hearing loss, unspecified) — no DFNA2A-specific code
ICD-11	AB52.x (sensorineural hearing impairment) — no DFNA2A-specific code
MeSH	Related term "Hearing Loss, Sensorineural" / "Deafness" — no DFNA2A-specific descriptor

Synonyms / alternative names: DFNA2A; deafness, autosomal dominant 2A; nonsyndromic hearing loss DFNA2; KCNQ4-related hearing loss. The locus name DFNA2 historically also encompassed DFNA2B (caused by GJB3); DFNA2A specifically denotes the KCNQ4-related entity.

Information source: Disease-level aggregated resources (OMIM, Orphanet, ClinVar) plus individual pedigree/case reports in the primary literature. No large EHR/registry-level dataset was analyzed in this investigation.

2. Etiology

Causal factors: Purely genetic — heterozygous pathogenic variants in KCNQ4. There is no infectious or primary environmental cause.

Genetic risk factors: The disease-defining variants are the risk factors. Two mechanistic classes: (1) dominant-negative pore-region missense variants (e.g., p.W276S, p.G228D, p.G321S, p.W275C) that abolish channel current; (2) truncating/haploinsufficiency variants. Dominant-negative variants confer more severe phenotypes.

Environmental risk / modifying factors: Aminoglycoside antibiotics and other PIP2-depleting ototoxins may accelerate or exacerbate loss in genetically susceptible individuals (PMID: 20935082). Noise exposure and age (presbycusis) are plausible additive insults on an already vulnerable OHC population, though direct DFNA2A-specific quantification is not available.

Protective factors: No specific genetic or environmental protective factors are documented. By inference, avoidance of ototoxic and PIP2-depleting agents would be protective.

Gene-environment interaction: The PIP2 dependence of KCNQ4 provides a defined molecular interaction: environmental PIP2-depleting agents (aminoglycosides) converge on the same molecular target that is genetically compromised, predicting synergistic injury.

3. Phenotypes

Phenotype	Type	HPO suggestion	Onset	Severity	Progression	Frequency
Sensorineural hearing loss	Clinical sign	HP:0000407 (Sensorineural hearing impairment)	Childhood–early adult	Mild→profound	Progressive	~All affected
High-frequency hearing loss (initial)	Clinical sign	HP:0000360 / HP:0008542 (High-frequency hearing impairment)	Early	Mild–moderate	Progressive to all frequencies	Characteristic initial pattern
Bilateral involvement	Clinical sign	HP:0008619 (Bilateral sensorineural hearing impairment)	—	—	—	Typical
Progressive course	Disease attribute	HP:0000408 (Progressive sensorineural hearing impairment)	—	—	Progressive	Typical
Mild vestibular dysfunction (subclinical)	Clinical sign	HP:0000365 (Hearing impairment) / vestibular	Variable	Mild	—	Minor; usually subclinical

The hearing loss is bilateral and symmetric, begins in the high frequencies, and progresses to involve all frequencies with age (PMID: 15699719; PMID: 35599357). Vestibular involvement is generally minimal in humans; mouse models reveal a mild vestibular dysfunction (altered vestibulo-ocular reflexes) attributable to postsynaptic KCNQ4 in calyx terminals, but not overt balance failure (PMID: 23408425).

Quality of life impact: Progressive hearing loss impairs speech communication, education, employment, and social participation, and is associated with increased risk of social isolation. DFNA2A-specific validated QoL metrics (EQ-5D, SF-36) were not identified in the available literature — a knowledge gap.

4. Genetic / Molecular Information

Causal gene: KCNQ4 (Kv7.4), 1p34.2, encoding a voltage-gated potassium channel that assembles as a homotetramer.
Variant types: Missense (dominant-negative, especially pore region), nonsense/frameshift (truncating, haploinsufficiency), splice-site. Representative variants: p.W276S (c.827G>C) hotspot; p.G228D; p.G321S (c.961G>A); p.W275C (c.825G>T).
Classification (ACMG/AMP): Recurrent variants such as p.W276S are classified pathogenic; novel variants require functional validation. Proactive saturation functional classification of KCNQ4 missense variants has been undertaken to resolve variants of uncertain significance (PMID: 35760561).
Allele frequency: Pathogenic variants are rare/absent in gnomAD (consistent with disease-causing status).
Origin: Germline (inherited dominant). Somatic origin is not relevant.
Functional consequences: Loss of function via dominant-negative poisoning of the tetramer (pore missense) or haploinsufficiency (truncating).
Modifier genes / epigenetics / chromosomal abnormalities: No established DFNA2A modifier genes, epigenetic mechanisms, or large-scale chromosomal abnormalities documented; DFNA2A is a point-variant disorder.

5. Environmental Information

Environmental contribution is limited to potential exacerbating exposures. Aminoglycoside antibiotics deplete PIP2 and inhibit KCNQ4-mediated I_K,n, providing a plausible route by which an environmental agent accelerates OHC dysfunction in the genetically susceptible ear (PMID: 20935082). No infectious agents cause DFNA2A. Lifestyle factors are not established causes but noise avoidance is prudent. CHEBI suggestions for relevant chemical entities: aminoglycoside (CHEBI:47779), phosphatidylinositol 4,5-bisphosphate (CHEBI:83417), potassium(1+) (CHEBI:29103).

6. Mechanism / Pathophysiology

Ordered causal chain (initiating lesion → clinical manifestation):

A heterozygous pathogenic KCNQ4 variant (dominant-negative pore missense, e.g., p.W276S, or truncating/haploinsufficiency allele) is present in the germline. → leads to
Mutant Kv7.4 subunits co-assemble with wild-type subunits into homotetramers; a single dominant-negative subunit abolishes current of the whole channel (or, for truncating alleles, channel dosage is halved). → results in
Loss of the standing basolateral potassium conductance I_K,n in cochlear outer hair cells (demonstrated) (PMID: 20935082). → leads to
Failure to extrude potassium that continuously enters through apical mechanotransduction channels; intracellular potassium accumulation and chronic OHC depolarization (inferred from channel physiology). → results in
Secondary calcium dysregulation and metabolic/ionic stress in OHCs (inferred). → leads to
Progressive OHC degeneration beginning in the cochlear base and advancing apically, mirroring the wild-type basal-to-apical KCNQ4 expression gradient (demonstrated in KO and knock-in mice) (PMID: 31102762; PMID: 35599357). → leads to
Branch: Loss of OHC electromotility/cochlear amplification → elevated high-frequency thresholds first (clinical high-frequency-onset SNHL). → and, later
Secondary (delayed by ~30 weeks in mouse) degeneration of inner hair cells and spiral ganglion neurons (PMID: 31102762). → results in
Progression to all-frequency, and ultimately severe-to-profound, bilateral symmetric sensorineural hearing loss.

Molecular pathways / biochemical basis: Potassium ion transport / recycling in the inner ear; voltage-gated potassium channel (Kv7/KCNQ) gating; PIP2-dependent channel regulation. This is fundamentally an ion channelopathy rather than a signaling-cascade disease.

Protein dysfunction: Recent structural and in vitro work refines subtype mechanisms — e.g., p.W275C (c.825G>T) did not alter channel localization, subunit assembly, or pore size but induced longitudinal extension of the channel, reduced protein stability, and impaired potassium ion selectivity (PMID: 41368761). A two-step voltage-sensor activation model for human Kv7.4 has been described (PMID: 41639121).

Cell types and biological processes involved: - Cell types (CL): Cochlear outer hair cell (CL:0000601), inner hair cell (CL:0000589), spiral ganglion neuron (CL:0000100). - GO biological process suggestions: potassium ion transmembrane transport (GO:0071805), potassium ion homeostasis (GO:0055075), sensory perception of sound (GO:0007605), regulation of membrane potential (GO:0042391). - GO cellular component: voltage-gated potassium channel complex (GO:0008076); basolateral plasma membrane (GO:0016323).

Upstream mechanisms: the channel loss and ionic overload. Downstream: hair-cell death and neuronal degeneration. There is no primary immune, metabolic, or fibrotic component; tissue damage arises from cell-intrinsic ionic stress.

7. Anatomical Structures Affected

Organ: Inner ear / cochlea (UBERON:0001844), specifically the organ of Corti (UBERON:0002227). Body system: auditory/nervous system (special sense).
Tissue/cell: Cochlear sensory epithelium — outer hair cells (primary), inner hair cells and spiral ganglion neurons (secondary). Vestibular calyx-forming afferent neurons show minor involvement in mice (PMID: 23408425).
Subcellular: Basolateral plasma membrane of OHCs (site of Kv7.4). GO cellular component: voltage-gated potassium channel complex (GO:0008076).
Localization/lateralization: Bilateral, symmetric; degeneration follows a basal→apical cochlear gradient (high→low frequency).

8. Temporal Development

Onset: Typically childhood to early adulthood; insidious and chronic. Age-dependent penetrance means early stages may be mild or subclinical.
Progression: Slowly progressive over decades; begins high-frequency and extends to all frequencies. Mouse models compress this: heterozygous humanized mice show mid/high-frequency loss by 4 weeks progressing to all frequencies by 12 weeks (PMID: 35599357).
Course/duration: Chronic, lifelong, progressive; no spontaneous remission.
Critical period: A therapeutic window exists while hair cells and neurons remain viable, before irreversible degeneration (PMID: 42162447).

9. Inheritance and Population

Inheritance: Autosomal dominant.
Penetrance: Age-dependent (incomplete at young ages, high with advancing age).
Expressivity: Variable; genotype-dependent — dominant-negative variants more severe than haploinsufficiency; gene dosage scales severity in models (PMID: 35599357).
Contribution: ~9.5% of autosomal dominant nonsyndromic hearing loss (PMID: 42162447).
Anticipation / mosaicism / founder effects / consanguinity: Not established features; DFNA2A is dominant and not a repeat-expansion disorder. Recurrent hotspot variants (W276S) arise independently across families rather than by a single founder.
Population/sex distribution: Reported across diverse populations (European and East Asian families in the cited literature); no strong sex predilection expected for an autosomal dominant channelopathy. Precise prevalence/incidence figures for DFNA2A specifically are not established in the available sources (knowledge gap).

10. Diagnostics

Audiometry: Pure-tone audiometry demonstrating bilateral, symmetric, high-frequency-onset progressive sensorineural loss is the core clinical test.
Electrophysiology: Auditory brainstem response (ABR) and otoacoustic emissions (OAE, reflecting OHC function) support the sensorineural, OHC-centered nature.
Genetic testing: Definitive diagnosis is molecular. Approaches: comprehensive hereditary hearing loss gene panels (including KCNQ4), whole exome sequencing, and targeted KCNQ4 single-gene/hotspot testing (e.g., for W276S). Functional classification resources assist VUS interpretation (PMID: 35760561).
Differential diagnosis: Other autosomal dominant nonsyndromic loci (e.g., other DFNA loci), presbycusis, noise-induced hearing loss, and syndromic hearing loss; distinguished by family history, audiometric pattern, and molecular testing.
Screening: Cascade genetic testing of at-risk relatives; newborn hearing screening detects those with early onset but is not disease-specific.

11. Outcome / Prognosis

Survival/mortality: DFNA2A does not affect life expectancy; there is no associated mortality.
Morbidity: Progressive hearing disability is the principal morbidity, affecting communication, education, employment, and quality of life.
Course: Chronic, progressive, non-remitting. Without intervention, many patients reach severe-to-profound loss with age.
Prognostic factors: Genotype (dominant-negative vs haploinsufficiency) predicts severity/rate; age is the dominant determinant of accumulated loss.
Recovery potential: Currently none for lost hair cells; preclinical gene-based correction restores function only if applied before irreversible cell loss (PMID: 42162447).

12. Treatment

Current standard of care (supportive): - Hearing aids in early/moderate stages (NCIT: Hearing Aid, C50069). - Cochlear implantation in advanced/profound stages (NCIT: Cochlear Implant, C50033). - Avoidance of ototoxic/PIP2-depleting agents (e.g., aminoglycosides) given the mechanistic vulnerability (PMID: 20935082).

There is no approved pharmacotherapy (PMID: 34316018).

Emerging / experimental (preclinical), matched to variant mechanism:

Strategy	Target variant class	Model	Key result	PMID
PIP2 / channel-activity modulation	Loss-of-function	in vitro	Proposed mechanism-based restoration of channel activity	34316018
Allele-selective ASO (ASO-123)	Dominant-negative p.W276S/W277S	Knock-in mouse	Preferential mutant knockdown; attenuated hearing loss; improved OHC survival/function	40898620
AAV adenine base editing (ABE8e)	Correctable point variant (p.G321S)	Humanized mouse	21.4–28.9% correction; ABR improved up to 49.09 dB SPL; durable ≥32 weeks	42162447

Pharmacogenomics / personalized medicine: Therapy choice is inherently genotype-guided — ASOs for dominant-negative alleles, base editing for correctable point mutations, and PIP2-modulating small molecules for loss-of-function variants amenable to pharmacological rescue. NCIT suggestions: Gene Therapy (C15254), Antisense Oligonucleotide Therapy (C1516/related), Cochlear Implant (C50033), Hearing Aid (C50069).

13. Prevention

Primary prevention: Not possible for a germline dominant disorder, but avoidance of ototoxic exposures reduces additive injury.
Secondary prevention: Early audiometric surveillance in at-risk families and early genetic diagnosis enable timely amplification and, prospectively, early molecular intervention within the therapeutic window.
Tertiary prevention: Hearing aids/cochlear implants and aural rehabilitation to preserve communication and prevent secondary social/cognitive complications.
Genetic counseling: Autosomal dominant inheritance implies 50% transmission risk to offspring; counseling, cascade testing, and reproductive options (PGT-M, prenatal testing) are appropriate.

14. Other Species / Natural Disease

Taxonomy: Homo sapiens (NCBI:txid9606). Modeled in Mus musculus (NCBI:txid10090) and Danio rerio (NCBI:txid7955).
Orthologs: Mouse Kcnq4; zebrafish kcnq4. Zebrafish kcnq4 is essential for inner-ear development — morpholino knockdown reduces hair-cell numbers and disrupts otolith morphology, rescued by wild-type mRNA (PMID: 41368761).
Natural disease in other species: No well-characterized spontaneous KCNQ4 deafness in companion animals/wildlife identified in the available literature; mechanisms are evolutionarily conserved across vertebrate hair cells.

15. Model Organisms

Model	Type	Key features	Recapitulation	PMID
Kcnq4 knockout (C3H/HeJ)	Mammalian, KO	OHC death by wk 3; IHC/neuron loss ~30 wk later; basal→apical gradient	High for degeneration cascade	31102762
Humanized p.G228D knock-in	Mammalian, knock-in	Dominant progressive loss; dosage-scaled severity; basal→apical OHC loss	High; models dominant human variant	35599357
p.W277S knock-in	Mammalian, knock-in	Models human W276S; used for ASO therapy testing	High for hotspot variant	40898620
Kcnq4^dn/dn / Kcnq5^dn/dn	Mammalian, dominant-negative	Reveal vestibular calyx roles; mild VOR changes	Partial (vestibular)	23408425
Zebrafish kcnq4 morphant	Vertebrate, knockdown	Reduced hair cells, otolith defects, abnormal motor response; mRNA-rescuable	Developmental; useful for variant validation	41368761

Limitations of models: Mouse timelines are highly compressed relative to the decades-long human course; zebrafish morphants model developmental rather than progressive adult-onset degeneration. Vestibular phenotypes in mice are more apparent than in humans.

Mechanistic Model / Interpretation

   Heterozygous KCNQ4 variant (germline)
|
|  dominant-negative pore missense (e.g., W276S)   OR   truncating / haploinsufficiency
v
   Defective Kv7.4 tetramer  -- one mutant subunit poisons whole channel -->  loss of I_K,n
|
v
   OHC cannot extrude K+ entering via apical mechanotransduction
|
v
   Chronic OHC depolarization + K+/Ca2+ overload  (inferred)
|
v
   Progressive OHC degeneration  (basal ---> apical, tracks KCNQ4 expression gradient)
|
|--> loss of cochlear amplification --> HIGH-FREQUENCY SNHL (early, clinical)
|
'--> (delayed ~30 wk in mouse) IHC + spiral ganglion neuron degeneration
                              |
                              v
          ALL-FREQUENCY, SEVERE-TO-PROFOUND, BILATERAL SNHL

   Environmental modifier:  aminoglycosides deplete PIP2 --> further inhibit I_K,n --> accelerated injury
   Therapeutic window:      correction/rescue effective ONLY while hair cells + neurons remain viable

The coherence of this model rests on convergent evidence: the original human genetics and dominant-negative electrophysiology (PMID: 10025409), the I_K,n/PIP2 dependence of OHC survival (PMID: 20935082), the spatiotemporal degeneration cascade in KO and knock-in mice (PMID: 31102762; PMID: 35599357), and the therapeutic reversibility within a viability window (PMID: 42162447; PMID: 40898620). Steps 4–5 (K+/Ca2+ overload) are the least directly demonstrated and are inferred from channel physiology.

Evidence Base

PMID	Title (abbrev.)	Role in this report
10025409	KCNQ4 ... mutated in dominant deafness	Foundational: gene discovery, OHC expression, dominant-negative pore mechanism (F001)
15699719	Phenotype-guided genotyping of a DFNA2/KCNQ4 family (W276S)	W276S hotspot; characteristic progressive AD SNHL phenotype (F002, F005)
40898620	ASO therapy mitigates DFNA2 hearing loss	Allele-selective ASO-123; hotspot/dominant-negative status (F002, F004)
42162447	Base editing restores auditory function in DFNA2 mouse	~9.5% ADNSHL contribution; base-editing rescue; therapeutic window (F002, F004, F007)
31102762	IHC and neuron degeneration in DFNA2-like mouse	Basal→apical OHC then IHC/neuron cascade (F003)
35599357	Humanized p.G228D mouse	Dosage-scaled severity; basal→apical degeneration (F003, F005)
20935082	Aminoglycosides inhibit KCNQ4 via PIP2 depletion	I_K,n/PIP2 dependence; gene-environment interaction (F003, F006)
34316018	Novel KCNQ4 variants; genotype/mechanism therapeutics	Loss-of-function variants; PIP2-based pharmacotherapy; no approved drug (F004)
35760561	Proactive functional classification of KCNQ4 missense SNVs	Supports VUS interpretation / diagnostics (Sec. 4, 10)
41368761	KCNQ4 p.W275C mechanism; zebrafish model	Protein-stability/selectivity defect; zebrafish model (Sec. 6, 14, 15)
41639121	Two-step voltage-sensor activation of human Kv7.4	Structural/gating detail (Sec. 6)
40752593	Early cochlear damage from potassium channel deficiency	Supports early-damage concept (Sec. 6, 8)
23408425	Vestibular role of KCNQ4/KCNQ5	Minor vestibular involvement; calyx localization (Sec. 3, 7, 15)

Limitations and Knowledge Gaps

Epidemiology: No precise DFNA2A-specific prevalence or incidence figures are available; only the ~9.5% contribution to ADNSHL is quantified. This is a literature-level gap, not resolvable from the sources reviewed.
Quality of life: No DFNA2A-specific validated QoL instrument data (EQ-5D, SF-36, PROMIS) were located.
Inferred mechanistic steps: Chronic K+/Ca2+ overload driving OHC death is inferred from channel physiology rather than directly measured in DFNA2A tissue.
Human vs model timelines: Mouse and zebrafish models compress or alter the decades-long, adult-onset human progression, limiting direct translation of timing.
Modifier genetics: No modifier genes or epigenetic contributors to variable expressivity have been identified.
Therapeutics are preclinical: ASO, base-editing, and PIP2-modulator approaches are not yet in human trials for DFNA2A.

Proposed Follow-up Experiments / Actions

Direct ionic imaging in humanized DFNA2A OHCs (K+/Ca2+ reporters) to confirm the inferred overload steps (4–5) of the causal chain.
Natural history registry to establish DFNA2A prevalence, penetrance-by-age curves, and genotype–progression correlations for dominant-negative vs haploinsufficiency alleles.
Genotype-stratified QoL study using validated hearing-specific instruments (e.g., HHIA, SSQ) across DFNA2A variant classes.
Define the therapeutic window quantitatively by mapping ASO/base-editing efficacy against age/degeneration stage to guide clinical intervention timing.
Clinical translation planning for allele-selective ASOs (W276S hotspot) and AAV base editing, including delivery, immunogenicity, and off-target assessment.
Prospective ototoxicity-avoidance guidance for KCNQ4 variant carriers, given the mechanistic PIP2 vulnerability to aminoglycosides.

Consensus Answer

Autosomal Dominant Nonsyndromic Hearing Loss 2A (DFNA2A; MONDO:0010817, OMIM #600101) is a monogenic potassium channelopathy caused by heterozygous pathogenic variants in KCNQ4 (Kv7.4, 1p34.2), which generates the I_K,n conductance in cochlear outer hair cells and accounts for roughly 9.5% of autosomal dominant nonsyndromic hearing loss. Loss of this conductance — via dominant-negative pore variants (e.g., the recurrent W276S hotspot) or haploinsufficiency truncations, both PIP2-dependent — chronically depolarizes outer hair cells and drives progressive basal-to-apical outer-hair-cell (then inner-hair-cell and spiral-ganglion-neuron) degeneration, producing bilateral, symmetric, progressive, high-frequency-onset sensorineural hearing loss with age-dependent penetrance. Management is currently supportive (hearing aids, cochlear implants) with no approved pharmacotherapy, while allele-selective antisense oligonucleotides, AAV adenine base editing, and PIP2/channel-modulating strategies show durable rescue in preclinical models within a hair-cell survival window.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	13
Resolved	13
Unresolved (possible confabulation)	0
Unverifiable	0
Quoted claims checked	15
Quoted claims found in source	15
Quoted claims not found in source	0
References weighed for topical relevance	13
On topic	13
Off topic	0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	22
Resolved	21
Unresolved (possible confabulation)	0
Obsolete	0
Unverifiable	1
Terms whose name was checked	8
Terms named correctly	4
Terms named as a different term	2
Terms whose name is worth a second look	2

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

MONDO:0010817 (3 mentions) - the report calls it "MONDO"; MONDO calls it autosomal dominant nonsyndromic hearing loss 2A
UBERON:0001844 (1 mention) - the report calls it "Organ: Inner ear / cochlea"; UBERON calls it cochlea**

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

GO:0071805 (1 mention) - the report calls it "GO biological process suggestions: potassium ion transmembrane transport"; GO calls it potassium ion transmembrane transport**
GO:0008076 (2 mentions) - the report calls it "GO cellular component: voltage-gated potassium channel complex"; GO calls it voltage-gated potassium channel complex**

Ask OpenScientist

OpenScientist Report

Inheritance

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Environmental Factors

Diagnosis

Animal Models

Source YAML

References & Deep Research

References

Deep Research

Autosomal Dominant Nonsyndromic Hearing Loss 2A (DFNA2A): Comprehensive Disease Characteristics Report

Summary

Key Findings

Finding 1 — DFNA2A is caused by dominant KCNQ4 (Kv7.4) potassium channel mutations acting on outer hair cells [H][V]

Finding 2 — KCNQ4 p.W276S is a mutational hotspot, and two mechanistic classes of variants exist [H][V]

Finding 3 — Causal chain: KCNQ4 loss → OHC potassium overload/depolarization → basal-to-apical hair cell then neuron degeneration [M][V]

Finding 4 — Emerging genotype/mechanism-based therapeutics: PIP2 modulation, allele-selective ASOs, and base editing [M][V]

Finding 5 — Phenotype is bilateral, symmetric, progressive high-frequency-onset SNHL with age-dependent penetrance; genotype scales severity [H][M]

Finding 6 — KCNQ4 activity is PIP2-dependent, linking genetic loss to aminoglycoside ototoxicity (gene-environment interaction) [V]

Finding 7 — DFNA2A is autosomal dominant with age-dependent penetrance; KCNQ4 is a leading ADNSHL gene treatable within a hair-cell survival window [H][M]

Report by Requested Sections

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic / Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome / Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Mechanistic Model / Interpretation

Evidence Base

Limitations and Knowledge Gaps

Proposed Follow-up Experiments / Actions

Consensus Answer

Artifacts

Reference Validation

Term Validation

Terms the report names something else

Terms whose name is worth a second look